|
102L
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME
Deposited 1992-09-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.74 Å
|
|
103L
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME
Deposited 1992-09-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
104L
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME
Deposited 1992-09-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
104L
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME
Deposited 1992-09-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
107L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
108L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
109L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
110L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
111L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
112L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
113L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
114L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
115L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1992-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
118L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
119L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.65 Å
|
|
120L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
122L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
123L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
125L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
126L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
127L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
128L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
129L
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED BY RELAXATION OF STRAIN AND BY IMPROVED HYDROGEN BONDING VIA BOUND SOLVENT
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
130L
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED BY RELAXATION OF STRAIN AND BY IMPROVED HYDROGEN BONDING VIA BOUND SOLVENT
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
131L
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED BY RELAXATION OF STRAIN AND BY IMPROVED HYDROGEN BONDING VIA BOUND SOLVENT
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
137L
STRUCTURAL BASIS OF AMINO ACID ALPHA HELIX PROPENSITY
Deposited 1993-08-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
137L
STRUCTURAL BASIS OF AMINO ACID ALPHA HELIX PROPENSITY
Deposited 1993-08-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
138L
RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKING
Deposited 1993-09-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
139L
RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKING
Deposited 1993-09-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
139L
RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKING
Deposited 1993-09-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 4
BME BETA-MERCAPTOETHANOL × 4
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
140L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
141L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
142L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
143L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
144L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
145L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
146L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
147L
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME
Deposited 1993-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
148L
A COVALENT ENZYME-SUBSTRATE INTERMEDIATE WITH SACCHARIDE DISTORTION IN A MUTANT T4 LYSOZYME
Deposited 1993-10-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
149L
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1994-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.60 Å
|
|
150L
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1994-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
150L
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1994-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
150L
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1994-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
150L
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1994-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
151L
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1994-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
152L
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1994-01-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–163(163 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
155L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
156L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
157L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
158L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
159L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
160L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
161L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
162L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
163L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
164L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
165L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
166L
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND
Deposited 1994-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
167L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–163(163 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
167L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–163(163 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
168L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
168L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
168L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
168L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
168L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
169L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.00 Å
|
|
169L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.00 Å
|
|
169L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.00 Å
|
|
169L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.00 Å
|
|
169L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.00 Å
|
|
170L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.60 Å
|
|
171L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
|
|
172L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
173L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
174L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.30 Å
|
|
174L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.30 Å
|
|
175L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
175L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
176L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
176L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
|
|
177L
Protein flexibility and adaptability seen in 25 crystal forms of T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, D127C, R154C
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.6;pH 8.6
|
Resolution 2.50 Å
|
|
178L
Protein flexibility and adaptability seen in 25 crystal forms of T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, D127C, R154C
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.71 Å
|
|
180L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T26E, C54T, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
180L
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME
Deposited 1995-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T26E, C54T, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
181L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
182L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
BZF BENZOFURAN × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
183L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
DEN INDENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
184L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
I4B ISOBUTYLBENZENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
185L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
IND INDOLE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
186L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
N4B N-BUTYLBENZENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
187L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
PXY PARA-XYLENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
188L
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY
Deposited 1995-04-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
OXE ORTHO-XYLENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
189L
ENHANCEMENT OF PROTEIN STABILITY BY THE COMBINATION OF POINT MUTATIONS IN T4 LYSOZYME IS ADDITIVE
Deposited 1995-05-09
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
|
|
190L
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS
Deposited 1995-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:N53A, N55A, V57A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
191L
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS
Deposited 1995-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:N53A, N55A, V57A, E128A, V131A, N132A
|
CL CHLORIDE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.95 Å
|
|
192L
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS
Deposited 1995-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:N40A, S44A, E45A, D47A, K48A, C54T, C97A, D127A, E128A, V131A, N132A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
195L
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME
Deposited 1995-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, A129L
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 1.90 Å
|
|
196L
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME
Deposited 1995-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, A129M
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 2.30 Å
|
|
197L
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME
Deposited 1995-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, A129M, F153A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 2.10 Å
|
|
198L
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME
Deposited 1995-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L121A, A129L
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 2.00 Å
|
|
199L
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME
Deposited 1995-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L121A, A129M
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 1.85 Å
|
|
1B6I
T4 LYSOZYME MUTANT WITH CYS 54 REPLACED BY THR, CYS 97 REPLACED BY ALA, THR 21 REPLACED BY CYS AND LYS 124 REPLACED BY CYS (C54T,C97A,T21C,K124C)
Deposited 1999-01-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,T21C,K124C
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.0
|
Resolution 1.90 Å
|
|
1C60
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C61
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 3
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C62
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.30 Å
|
|
1C63
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C64
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C65
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C66
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
AR ARGON × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.10 Å
|
|
1C67
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.20 Å
|
|
1C68
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.50 Å
|
|
1C69
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.80 Å
|
|
1C6A
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.10 Å
|
|
1C6B
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.20 Å
|
|
1C6C
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
AR ARGON × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C6D
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C6E
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 2 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 1
XE XENON × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6F
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 32 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
AR ARGON × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1C6G
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6H
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 3
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6I
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
AR ARGON × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6J
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6K
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6L
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6M
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 4
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.10 Å
|
|
1C6N
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 4
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.20 Å
|
|
1C6P
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM ARGON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6Q
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM KRYPTON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
KR KRYPTON × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 1.90 Å
|
|
1C6T
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM XENON
Deposited 1999-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
XE XENON × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8-2.2 M NAH2/K2HPO4, PH 6.9-7.1, 50 MM BETA-MERCAPTOETHANOL AND/OR 50 MM HYDROXYETHYL DISULFIDE
|
Resolution 2.00 Å
|
|
1CTW
T4 LYSOZYME MUTANT I78A
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, I78A, C97A
|
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;277 K;NA2PO4, NACL, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.10 Å
|
|
1CU0
T4 LYSOZYME MUTANT I78M
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, I78M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
|
|
1CU2
T4 LYSOZYME MUTANT L84M
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L84M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.85 Å
|
|
1CU3
T4 LYSOZYME MUTANT V87M
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, V87M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.12 Å
|
|
1CU5
T4 LYSOZYME MUTANT L91M
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L91M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.05 Å
|
|
1CU6
T4 LYSOZYME MUTANT L91A
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L91A, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.10 Å
|
|
1CUP
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, I100M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.89 Å
|
|
1CUQ
T4 LYSOZYME MUTANT V103M
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V103M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.05 Å
|
|
1CV0
T4 LYSOZYME MUTANT F104M
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, F104M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.12 Å
|
|
1CV1
T4 LYSOZYME MUTANT V111M
Deposited 1999-08-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, V111M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.10 Å
|
|
1CV3
T4 LYSOZYME MUTANT L121M
Deposited 1999-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L121M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
|
|
1CV4
T4 LYSOZYME MUTANT L118M
Deposited 1999-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L118M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.90 Å
|
|
1CV5
T4 LYSOZYME MUTANT L133M
Deposited 1999-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L133M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.87 Å
|
|
1CV6
T4 LYSOZYME MUTANT V149M
Deposited 1999-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V149M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.90 Å
|
|
1CVK
T4 LYSOZYME MUTANT L118A
Deposited 1999-08-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L118A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.80 Å
|
|
1CX6
T4 LYSOZYME SUBSTITUTED WITH SELENOMETHIONINE
Deposited 1999-08-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L84(MSE), L91(MSE), C97A, L99(MSE), L118(MSE), L121(MSE), L133(MSE), F153(MSE)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;NA2PO4, NACL, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.01 Å
|
|
1CX7
T4 LYSOZYME METHIONINE CORE MUTANT
Deposited 1999-08-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L84M, L91M, C97A, L99M, L118M, L121M, L133M, F153M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;Na2PO4, NaCl, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.94 Å
|
|
1D2W
N-TERMINAL DOMAIN CORE METHIONINE MUTATION
Deposited 1999-09-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I27M, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;NA2PO4, NACL, pH 6.9, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.89 Å
|
|
1D2Y
N-TERMINAL DOMAIN CORE METHIONINE MUTATION
Deposited 1999-09-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I50M, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;NA2PO4, NACL, pH 6.9, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.06 Å
|
|
1D3F
N-TERMINAL DOMAIN CORE METHIONINE MUTATION
Deposited 1999-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, I58M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;NA2PO4, NACL , pH 6.9, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.05 Å
|
|
1D3J
N-TERMINAL DOMAIN CORE METHIONINE MUTATION
Deposited 1999-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L66M, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;NA2PO4, NACL , pH 6.9, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.97 Å
|
|
1D3M
METHIONINE CORE MUTATION
Deposited 1999-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L84M, L91M, C97A, L99M, L118M, L121M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;NA2PO4, NACL, pH 6.9, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.12 Å
|
|
1D3N
METHIONINE CORE MUTATION
Deposited 1999-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L84(MSE), L91(MSE), C97A, L99(MSE), L118(MSE), L121(MSE)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;NA2PO4, NACL, pH 7.0, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.00 Å
|
|
1D9W
BACTERIOPHAGE T4 LYSOZYME MUTANT
Deposited 1999-10-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:K124D
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;2.1-M phosphate, 10 mM BME, 20 mM oxBME, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.91 Å
|
|
1DYA
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1993-05-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1DYB
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1993-05-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
1DYC
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1993-05-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
1DYD
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1993-05-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
1DYE
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1993-05-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1DYF
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1993-05-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1DYG
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1993-05-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
1EPY
T4 LYSOZYME MUTANT, T21H/C54T/C97A/Q141H/T142H
Deposited 2000-03-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21H,C54T,C97A,Q141H,T142H
|
SO4 SULFATE ION × 1
CL CHLORIDE ION × 1
CO COBALT (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;12-16% PEG 8000, 10% isopropanol, sodium chloride, HEPES, 0.002 M cobalt chloride, pH 7.0, VAPOR DIFFUSION, HANGING
DROP, temperature 4K
|
Resolution 1.85 Å
|
|
1G06
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149S
Deposited 2000-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; V149S
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;300 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
Resolution 1.85 Å
|
|
1G07
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149C
Deposited 2000-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; V149S
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;300 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
Resolution 1.70 Å
|
|
1G0G
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152A
Deposited 2000-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; T152A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
|
|
1G0J
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152S
Deposited 2000-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; T152S
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
|
|
1G0K
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152C
Deposited 2000-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; T152C
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.85 Å
|
|
1G0L
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152V
Deposited 2000-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; T152V
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
|
|
1G0M
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152I
Deposited 2000-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; T152I
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.70 Å
|
|
1G0P
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149G
Deposited 2000-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; T152S
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
|
|
1G0Q
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149I
Deposited 2000-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T; C97A; V149I
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;Phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
|
|
1G1V
T4 LYSOZYME MUTANT C54T/C97A/I58T
Deposited 2000-10-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/I58T
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.1 M NAH2/K2HPO4, 50 MM HYDROXYETHYL DISULFIDE, pH 7.10, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
|
|
1G1W
T4 LYSOZYME MUTANT C54T/C97A/Q105M
Deposited 2000-10-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/Q105M
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;1.8 M NAH2/K2HPO4, 50 MM BETA-MERCAPTOETHANOL, pH 7.10, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
|
|
1I6S
T4 LYSOZYME MUTANT C54T/C97A/N101A
Deposited 2001-03-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,N101A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1JQU
Are Carboxy Terminii of Helices Coded by the Local Sequence or by Tertiary Structure Contacts
Deposited 2001-08-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, W158L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.75;277 K;30% PEG4000, PIPES buffer ph7.0, 0.2M LiSO4, pH 6.75, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å
R-free 0.316
|
|
1JQU
Are Carboxy Terminii of Helices Coded by the Local Sequence or by Tertiary Structure Contacts
Deposited 2001-08-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:C54T, C97A, W158L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.75;277 K;30% PEG4000, PIPES buffer ph7.0, 0.2M LiSO4, pH 6.75, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å
R-free 0.316
|
|
1JQU
Are Carboxy Terminii of Helices Coded by the Local Sequence or by Tertiary Structure Contacts
Deposited 2001-08-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Mutation:C54T, C97A, W158L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.75;277 K;30% PEG4000, PIPES buffer ph7.0, 0.2M LiSO4, pH 6.75, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å
R-free 0.316
|
|
1JQU
Are Carboxy Terminii of Helices Coded by the Local Sequence or by Tertiary Structure Contacts
Deposited 2001-08-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Mutation:C54T, C97A, W158L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.75;277 K;30% PEG4000, PIPES buffer ph7.0, 0.2M LiSO4, pH 6.75, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å
R-free 0.316
|
|
1JTM
Alternative Structures of a Sequence Extended T4 Lysozyme Show that the Highly Conserved Beta-Sheet has Weak Intrinsic Folding Propensity
Deposited 2001-08-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;50MM TRIS-GLYCINE, 20% PEG 8000, 10% Isopropanol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.90 Å
R-free 0.265
|
|
1JTN
Alternative Structures of a Sequence Extended T4 Lysozyme Show that the Highly Conserved Beta-Sheet Region has weak intrinsic Folding Propensity
Deposited 2001-08-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;298 K;50m Tris-Glycine, 200mM Lisulfate, 18% PEG 4000, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.314
|
|
1JTN
Alternative Structures of a Sequence Extended T4 Lysozyme Show that the Highly Conserved Beta-Sheet Region has weak intrinsic Folding Propensity
Deposited 2001-08-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:C54T, C97A
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;298 K;50m Tris-Glycine, 200mM Lisulfate, 18% PEG 4000, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.314
|
|
1KNI
Stabilizing Disulfide Bridge Mutant of T4 Lysozyme
Deposited 2001-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C,T142C,C54T,C97A
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1KS3
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 2002-01-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L118M,L121M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;Na2PO4, NaCl, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.16 Å
|
|
1KW5
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 2002-01-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,L84M,L91M,C97A,L99M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;Na2PO4, NaCl, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.75 Å
|
|
1KW7
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 2002-01-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,L84M,L91M,C97A,L99M,L133M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;Na2Po4, NaCl, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.89 Å
|
|
1KY0
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 2002-02-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,L84M,L91M,C97A,L99M,F153M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;Na2PO4, NaCl, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.97 Å
|
|
1KY1
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 2002-02-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,L84M,L91M,C97A,L99M,L118M,L121M,L133M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;Na2PO4, NaCl, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.05 Å
|
|
1L00
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTURE, STABILITY, SOLVATION, AND SPECTROSCOPIC PROPERTIES
Deposited 1992-07-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L01
STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT PROTEIN THR157 (RIGHT ARROW) ILE
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L02
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L03
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L04
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L05
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L06
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L07
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L08
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L09
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L0J
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 2002-02-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,L84M,L91M,C97A,L99M,L118M,L121M,F153M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;Na2PO4, NaCl, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.98 Å
|
|
1L0K
METHIONINE CORE MUTANT OF T4 LYSOZYME
Deposited 2002-02-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,L84M,L91M,C97A,L99M,V111M,L118M,L121M,L133M
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;Na2PO4, NaCl, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.02 Å
|
|
1L10
STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT PROTEIN THR157 (RIGHT ARROW) ILE
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L11
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L12
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L13
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L14
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L15
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L16
STRUCTURAL ANALYSIS OF THE TEMPERATURE-SENSITIVE MUTANT OF BACTERIOPHAGE T4 LYSOZYME, GLYCINE 156 (RIGHT ARROW) ASPARTIC ACID
Deposited 1988-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L17
HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L18
HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L19
ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLES
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L20
ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLES
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L21
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LYSOZYME
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L22
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LYSOZYME
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L23
ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDING
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L24
ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDING
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L25
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L26
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L27
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L28
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L29
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L30
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L31
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L32
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L33
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LYSOZYME
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L34
HIGH-RESOLUTION STRUCTURE OF THE TEMPERATURE-SENSITIVE MUTANT OF PHAGE LYSOZYME, ARG 96 (RIGHT ARROW) HIS
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L35
STRUCTURE OF A THERMOSTABLE DISULFIDE-BRIDGE MUTANT OF PHAGE T4 LYSOZYME SHOWS THAT AN ENGINEERED CROSSLINK IN A FLEXIBLE REGION DOES NOT INCREASE THE RIGIDITY OF THE FOLDED PROTEIN
Deposited 1989-10-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–163(163 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L36
TOWARD A SIMPLIFICATION OF THE PROTEIN FOLDING PROBLEM: A STABILIZING POLYALANINE ALPHA-HELIX ENGINEERED IN T4 LYSOZYME
Deposited 1990-12-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L37
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L38
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L39
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L40
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L41
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
1L42
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L43
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L44
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L45
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L46
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L47
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L48
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L49
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L50
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L51
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L52
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L53
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L54
THE STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF BURYING A CHARGED RESIDUE WITHIN THE HYDROPHOBIC CORE OF T4 LYSOZYME
Deposited 1991-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L55
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L56
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L57
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L58
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.65 Å
|
|
1L59
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
1L60
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L61
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L62
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L63
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME
Deposited 1991-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
1L64
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L65
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L66
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L67
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L68
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L69
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L70
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L71
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L72
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L73
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.05 Å
|
|
1L74
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L75
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L76
TOLERANCE OF T4 LYSOZYME TO PROLINE SUBSTITUTIONS WITHIN THE LONG INTERDOMAIN ALPHA-HELIX ILLUSTRATES THE ADAPTABILITY OF PROTEINS TO POTENTIALLY DESTABILIZING LESIONS
Deposited 1991-09-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L77
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-11-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.05 Å
|
|
1L79
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-11-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L80
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-11-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L81
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-11-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1L82
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1991-11-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
1L83
A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENE
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L84
A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENE
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L85
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1L86
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L87
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L88
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1L89
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1L90
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
1L91
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L92
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1L93
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L94
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L95
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES
Deposited 1992-01-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1L96
STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO
Deposited 1992-02-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1L97
STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO
Deposited 1992-02-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1L97
STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO
Deposited 1992-02-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1L98
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTURE, STABILITY, SOLVATION, AND SPECTROSCOPIC PROPERTIES
Deposited 1992-07-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1L99
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTURE, STABILITY, SOLVATION, AND SPECTROSCOPIC PROPERTIES
Deposited 1992-07-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.95 Å
|
|
1LGU
T4 Lysozyme Mutant L99A/M102Q
Deposited 2002-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1LGW
T4 Lysozyme Mutant L99A/M102Q Bound by 2-fluoroaniline
Deposited 2002-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
1AN 2-FLUOROANILINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1LGX
T4 Lysozyme Mutant L99A/M102Q Bound by 3,5-difluoroaniline
Deposited 2002-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
5AN 3,5-DIFLUOROANILINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1LI2
T4 Lysozyme Mutant L99A/M102Q Bound by Phenol
Deposited 2002-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
IPH PHENOL × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1LI3
T4 lysozyme mutant L99A/M102Q bound by 3-chlorophenol
Deposited 2002-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
3CH 3-CHLOROPHENOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1LI6
T4 lysozyme mutant L99A/M102Q bound by 5-methylpyrrole
Deposited 2002-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
5MP 5-METHYLPYRROLE × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1LLH
ARE CARBOXY TERMINII OF HELICES CODED BY THE LOCAL SEQUENCE OR BY TERTIARY STRUCTURE CONTACTS
Deposited 2002-04-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, T157I
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;277 K;1.8M Phosphate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.242
|
|
1LPY
Multiple Methionine Substitutions in T4 Lysozyme
Deposited 2002-05-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,L84M,V87M,L91M,C97A,L99M,I100M,V103M,G110R,V111M,L118M,L121M,L133M
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.65 Å
|
|
1LW9
Multiple methionine substitutions are tolerated in T4 lysozyme and have coupled effects on folding and stability
Deposited 2002-05-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 1.45 Å
R-free 0.254
|
|
1LWG
Multiple Methionine Substitutions are Tolerated in T4 Lysozyme and have Coupled Effects on Folding and Stability
Deposited 2002-05-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,L84M,V87M,L91M,C97A,L99M,V111M,L118M,L121M,L133M
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 3
K POTASSIUM ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.70 Å
|
|
1LWG
Multiple Methionine Substitutions are Tolerated in T4 Lysozyme and have Coupled Effects on Folding and Stability
Deposited 2002-05-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,L84M,V87M,L91M,C97A,L99M,V111M,L118M,L121M,L133M
|
PO4 PHOSPHATE ION × 2
CL CHLORIDE ION × 6
K POTASSIUM ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.70 Å
|
|
1LWK
Multiple Methionine Substitutions are Tolerated in T4 Lysozyme and have Coupled Effects on Folding and Stability
Deposited 2002-05-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,L84MSE,V87MSE,L91MSE,C97A,L99MSE,G110R,V111MSE,L118MSE,L121MSE,L133MSE,F153MSE
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.10 Å
|
|
1LYD
CRYSTAL STRUCTURE OF T4-LYSOZYME GENERATED FROM SYNTHETIC CODING DNA EXPRESSED IN ESCHERICHIA COLI
Deposited 1989-01-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1LYE
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59
Deposited 1992-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1LYF
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59
Deposited 1992-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1LYG
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59
Deposited 1992-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1LYH
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59
Deposited 1992-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
1LYI
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59
Deposited 1992-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1LYJ
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59
Deposited 1992-08-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1NHB
Specificity of ligand binding in a buried non-polar cavity of t4 lysozyme: linkage of dynamics and structural plasticity
Deposited 1995-02-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
PYJ PHENYLETHANE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1OV5
T4 Lysozyme Cavity Mutant L99a/M102Q Bound With 2-Allylphenol
Deposited 2003-03-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
2LP 2-ALLYLPHENOL × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
1OV7
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with 2-Allyl-6-Methyl-Phenol
Deposited 2003-03-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
LYL 2-ALLYL-6-METHYL-PHENOL × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1OVH
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 2-Chloro-6-Methyl-Aniline
Deposited 2003-03-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
2CM 2-CHLORO-6-METHYL-ANILINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.95 Å
|
|
1OVJ
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with 3-Fluoro-2-Methyl_Aniline
Deposited 2003-03-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
FLM 3-FLUORO-2-METHYL-ANILINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1OVK
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with N-Allyl-Aniline
Deposited 2003-03-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
NYL N-ALLYL-ANILINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
1OWY
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 2-Propyl-Aniline
Deposited 2003-03-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
PRY 2-PROPYL-ANILINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1OWZ
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 4-FluoroPhenEthyl Alcohol
Deposited 2003-03-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
4FA 4-FLUOROPHENETHYL ALCOHOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1OYU
Long-Distance conformational changes in a protein engineered by modulated sequence duplication
Deposited 2003-04-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;25% poly-ethylene glycol 4000, 50mM phosphate buffer, 0.2mM ammonium acetate, 20% isopropanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.324
|
|
1OYU
Long-Distance conformational changes in a protein engineered by modulated sequence duplication
Deposited 2003-04-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;25% poly-ethylene glycol 4000, 50mM phosphate buffer, 0.2mM ammonium acetate, 20% isopropanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.324
|
|
1P2L
T4 Lysozyme Core Repacking Mutant V87I/TA
Deposited 2003-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, V87I, C97A
|
PO4 PHOSPHATE ION × 1
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;Potassium PHOSPHATE, Sodium Phosphate, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.58 Å
R-free 0.217
|
|
1P2R
T4 LYSOZYME CORE REPACKING MUTANT I78V/TA
Deposited 2003-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, I78V, C97A
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;Potassium Phosphate, Sodium phosphate, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.58 Å
R-free 0.245
|
|
1P36
T4 LYOSZYME CORE REPACKING MUTANT I100V/TA
Deposited 2003-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, I100V
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;Potassium PHOSPHATE, Sodium Phosphate, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.45 Å
R-free 0.226
|
|
1P37
T4 LYSOZYME CORE REPACKING BACK-REVERTANT L102M/CORE10
Deposited 2003-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, v87I, C97A, I100V, V103I, M106I, V111A, M120Y, L133F, V149I, T152V
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;2M sodium/potassium phosphate, 40 mM BME, 550 mM NaCl, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.57 Å
R-free 0.221
|
|
1P3N
CORE REDESIGN BACK-REVERTANT I103V/CORE10
Deposited 2003-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, V87I, I100V, M102L, M106I, V111A, M120Y, L133F, V149I, T152V, C97A
|
PO4 PHOSPHATE ION × 1
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;Potassium phosphate, sodium PHOSPHATE, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.55 Å
R-free 0.247
|
|
1P46
T4 lysozyme core repacking mutant M106I/TA
Deposited 2003-04-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M106I
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;Potassium/Sodium Phosphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.67 Å
R-free 0.240
|
|
1P56
Duplication-extension of Helix A of T4 lysozyme
Deposited 2003-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–163(163 aa)
|
Mutation:C54T, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;35% PEG 4000, 50mM phosphate buffer, 5% isopropanol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.80 Å
R-free 0.273
|
|
1P5C
Circular permutation of Helix A in T4 lysozyme
Deposited 2003-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
12–163(152 aa)
|
Mutation:C54T, C97A, G12M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;298 K;30% PEG 3400, 50mM Phosphate buffer, 5% isopropanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.310
|
|
1P5C
Circular permutation of Helix A in T4 lysozyme
Deposited 2003-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
12–163(152 aa)
|
Mutation:C54T, C97A, G12M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;298 K;30% PEG 3400, 50mM Phosphate buffer, 5% isopropanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.310
|
|
1P5C
Circular permutation of Helix A in T4 lysozyme
Deposited 2003-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
12–163(152 aa)
|
Mutation:C54T, C97A, G12M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;298 K;30% PEG 3400, 50mM Phosphate buffer, 5% isopropanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.310
|
|
1P5C
Circular permutation of Helix A in T4 lysozyme
Deposited 2003-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
12–163(152 aa)
|
Mutation:C54T, C97A, G12M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;298 K;30% PEG 3400, 50mM Phosphate buffer, 5% isopropanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.310
|
|
1P64
T4 LYSOZYME CORE REPACKING MUTANT L133F/TA
Deposited 2003-04-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L133F
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;K/Na Phosphate, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.62 Å
R-free 0.251
|
|
1P6Y
T4 LYSOZYME CORE REPACKING MUTANT M120Y/TA
Deposited 2003-04-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M120Y
|
PO4 PHOSPHATE ION × 1
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;K/Na Phosphate, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.54 Å
R-free 0.237
|
|
1P7S
T4 LYSOZYME CORE REPACKING MUTANT V103I/TA
Deposited 2003-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/V103I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;2M K/Na phosphate, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.50 Å
R-free 0.266
|
|
1PQD
T4 LYSOZYME CORE REPACKING MUTANT CORE10/TA
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/V87I/C97A/I100V/M102L/V103I/M106I/V111A/M120Y/L133F/V149I/T152V
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;Potassium phosphate, sodium PHOSPHATE, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 100K
|
Resolution 1.65 Å
|
|
1PQI
T4 LYSOZYME CORE REPACKING MUTANT I118L/CORE7/TA
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/I78V/V87M/C97A/L118I/M120Y/L133F/V149I/T152V
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;277 K;2 M Na/K Phosphate, 550 mM NaCl, 40 mM BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.70
|
Resolution 1.57 Å
R-free 0.266
|
|
1PQJ
T4 LYSOZYME CORE REPACKING MUTANT A111V/CORE10/TA
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/V87I/C97A/I100V/M102L/V103I/M106I/V111A/M120Y/L133F/V149I/T152V
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;Potassium phosphate, Sodium PHOSPHATE, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.269
|
|
1PQK
Repacking of the Core of T4 Lysozyme by Automated Design
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, G77A, I78V, C97A, L118I, M120Y, L133F, V149I, T152V
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;277 K;Potassium phosphate, sodium PHOSPHATE, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.70
|
Resolution 2.00 Å
R-free 0.277
|
|
1PQK
Repacking of the Core of T4 Lysozyme by Automated Design
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:C54T, G77A, I78V, C97A, L118I, M120Y, L133F, V149I, T152V
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;277 K;Potassium phosphate, sodium PHOSPHATE, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.70
|
Resolution 2.00 Å
R-free 0.277
|
|
1PQK
Repacking of the Core of T4 Lysozyme by Automated Design
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Mutation:C54T, G77A, I78V, C97A, L118I, M120Y, L133F, V149I, T152V
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;277 K;Potassium phosphate, sodium PHOSPHATE, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.70
|
Resolution 2.00 Å
R-free 0.277
|
|
1PQM
T4 Lysozyme Core Repacking Mutant V149I/T152V/TA
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/V149I/T152V
|
PO4 PHOSPHATE ION × 1
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;277 K;Potassium phosphate, sodium PHOSPHATE, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.70
|
Resolution 1.52 Å
R-free 0.219
|
|
1PQO
T4 Lysozyme Core Repacking Mutant L118I/TA
Deposited 2003-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/L118I
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;277 K;Potassium phosphate, sodium PHOSPHATE, NaCl, BME, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.70
|
Resolution 1.65 Å
R-free 0.261
|
|
1QS5
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, A98L
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;POTASSIUM PHOSPHATE, SODIUM PHOSPHATE, BME, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.50 Å
|
|
1QS9
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, A98V
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;POTASSIUM PHOSPHATE, SODIUM PHOSPHATE, BME, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.85 Å
|
|
1QSB
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:A98C, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.00
|
Resolution 1.80 Å
|
|
1QSQ
CAVITY CREATING MUTATION
Deposited 1999-06-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M106A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;277 K;NA2PO4, NACL, pH 6.6, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.90 Å
|
|
1QT3
T26D MUTANT OF T4 LYSOZYME
Deposited 1999-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T26D, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1QT4
T26Q MUTANT OF T4 LYSOZYME
Deposited 1999-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T26Q, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
1QT5
D20E MUTANT STRUCTURE OF T4 LYSOZYME
Deposited 1999-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D20E, C54T, C97A
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1QT6
E11H Mutant of T4 Lysozyme
Deposited 1999-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:E11H, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1QT7
E11N Mutant of T4 Lysozyme
Deposited 1999-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:E11N, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
1QT8
T26H Mutant of T4 Lysozyme
Deposited 1999-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T26H, C54T, C97A
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1QTB
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:A42V, C54T, C97A
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;potassium phosphate, sodium phosphate, BME, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
|
|
1QTC
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, A129F
|
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;POTASSIUM PHOSPHATE, SODIUM PHOSPHATE, BME, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.50 Å
|
|
1QTD
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, A129W
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;potassium phosphate, sodium phosphate, BME, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.50 Å
|
|
1QTH
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, A98M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;277 K;PEG3.4K, magnesium chloride, Hepes, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
|
|
1QTH
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME
Deposited 1999-06-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:C54T, C97A, A98M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;277 K;PEG3.4K, magnesium chloride, Hepes, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
|
|
1QTV
T26E APO STRUCTURE OF T4 LYSOZYME
Deposited 1999-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T26E, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.30 Å
|
|
1QTZ
D20C MUTANT OF T4 LYSOZYME
Deposited 1999-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D20C, C54T, C97A
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1QUD
L99G MUTANT OF T4 LYSOZYME
Deposited 1999-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, L99G
|
CL CHLORIDE ION × 2
HEZ HEXANE-1,6-DIOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.75 Å
|
|
1QUG
E108V MUTANT OF T4 LYSOZYME
Deposited 1999-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, E108V
|
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1QUH
L99G/E108V MUTANT OF T4 LYSOZYME
Deposited 1999-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, L99G, E108V
|
CL CHLORIDE ION × 2
HEZ HEXANE-1,6-DIOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
1QUO
L99A/E108V MUTANT OF T4 LYSOZYME
Deposited 1999-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, L99A, E108V
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1SSW
Crystal structure of phage T4 lysozyme mutant Y24A/Y25A/T26A/I27A/C54T/C97A
Deposited 2004-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:Y24A/Y25A/T26A/I27A/C54T/C97A
|
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.13 Å
R-free 0.215
|
|
1SSY
Crystal structure of phage T4 lysozyme mutant G28A/I29A/G30A/C54T/C97A
Deposited 2004-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:G28A/I29A/G30A/C54T/C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.40 Å
R-free 0.236
|
|
1SSY
Crystal structure of phage T4 lysozyme mutant G28A/I29A/G30A/C54T/C97A
Deposited 2004-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:G28A/I29A/G30A/C54T/C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.40 Å
R-free 0.236
|
|
1SWY
Use of a Halide Binding Site to Bypass the 1000-atom Limit to Ab initio Structure Determination
Deposited 2004-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D72A, R96E
|
RB RUBIDIUM ION × 5
CL CHLORIDE ION × 5
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;277 K;sodium:potassium phosphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.70
|
Resolution 1.06 Å
R-free 0.147
|
|
1SWZ
Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure determination by direct methods
Deposited 2004-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D72A, R96E
|
PO4 PHOSPHATE ION × 1
RB RUBIDIUM ION × 5
CL CHLORIDE ION × 4
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;sodium:potassium phosphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 100K, pH 6.70
|
Resolution 1.06 Å
R-free 0.151
|
|
1SX2
Use of a Halide Binding Site to Bypass the 1000-atom Limit to Structure Determination by Direct Methods
Deposited 2004-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D72A, R96E
|
RB RUBIDIUM ION × 5
CL CHLORIDE ION × 5
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;sodium:potassium phosphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 100K, pH 6.70
|
Resolution 1.06 Å
R-free 0.143
|
|
1SX7
Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure determination by direct methods
Deposited 2004-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D72A, R96E
|
RB RUBIDIUM ION × 5
CL CHLORIDE ION × 4
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;sodium:potassium phosphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 100K, pH 6.70
|
Resolution 1.06 Å
R-free 0.145
|
|
1T6H
Crystal Structure T4 Lysozyme incorporating an unnatural amino acid p-iodo-L-phenylalanine at position 153
Deposited 2004-05-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:F153(PIL)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;0.25M NaCl. 2.0M Na/K phosphate buffer, 15mM hydroxyethyl disulfide, pH 6.7, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.01 Å
R-free 0.210
|
|
1T8A
USE OF SEQUENCE DUPLICATION TO ENGINEER A LIGAND-TRIGGERED LONG-DISTANCE MOLECULAR SWITCH IN T4 Lysozyme
Deposited 2004-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L39I, R63A, C54T,C97A
|
CL CHLORIDE ION × 1
GAI GUANIDINE × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;1.8 M MIXED POTASSIUM AND SODIUM PHOSPHATE. 0.2 M GUANIDINIUM CHLORIDE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å
R-free 0.251
|
|
1T8F
Crystal structure of phage T4 lysozyme mutant R14A/K16A/I17A/K19A/T21A/E22A/C54T/C97A
Deposited 2004-05-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R14A,K16A,I17A,K19A,T21A,E22A,C54T,C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.15 Å
R-free 0.275
|
|
1T8G
Crystal structure of phage T4 lysozyme mutant L32A/L33A/T34A/C54T/C97A/E108V
Deposited 2004-05-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L32A,L33A,T34A,E108V,C54T,C97A
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
R-free 0.215
|
|
1T8G
Crystal structure of phage T4 lysozyme mutant L32A/L33A/T34A/C54T/C97A/E108V
Deposited 2004-05-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
1–164(164 aa)
|
Mutation:L32A,L33A,T34A,E108V,C54T,C97A
|
PO4 PHOSPHATE ION × 8
CL CHLORIDE ION × 16
BME BETA-MERCAPTOETHANOL × 8
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
R-free 0.215
|
|
1T97
Use of sequence duplication to engineer a ligand-triggered long-distance molecular switch in T4 Lysozyme
Deposited 2004-05-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;30% POLY-ETHYLENE GLYCOL 3400, 100MM HEPES BUFFER, 200MM AMMONIUM ACETATE, pH 7.50, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.70 Å
R-free 0.290
|
|
1T97
Use of sequence duplication to engineer a ligand-triggered long-distance molecular switch in T4 Lysozyme
Deposited 2004-05-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;30% POLY-ETHYLENE GLYCOL 3400, 100MM HEPES BUFFER, 200MM AMMONIUM ACETATE, pH 7.50, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.70 Å
R-free 0.290
|
|
1TLA
HYDROPHOBIC CORE REPACKING AND AROMATIC-AROMATIC INTERACTION IN THE THERMOSTABLE MUTANT OF T4 LYSOZYME SER 117 (RIGHT ARROW) PHE
Deposited 1993-03-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1XEP
Catechol in complex with T4 lysozyme L99A/M102Q
Deposited 2004-09-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A, M102Q
|
PO4 PHOSPHATE ION × 1
CAQ CATECHOL × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;phosphate, pH 6.8-7.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.55 Å
R-free 0.219
|
|
1ZUR
Crystal structure of spin labeled T4 Lysozyme (V131R1F)
Deposited 2005-05-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V131C
|
R1F S-[(1-oxyl-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;potassium phosphate, sodium phospahte, sodium choloride, sodium azide, oxidized beta-mercaptoehtanol, isopropanol, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.60 Å
R-free 0.214
|
|
1ZWN
Crystal structure of spin labeled T4 Lysozyme (V131R1B)
Deposited 2005-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V131C
|
R1B S-[(1-oxyl-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
AZI AZIDE ION × 2
CL CHLORIDE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;278 K;potassium phosphate, sodium phospahte, sodium choloride, sodium azide, oxidized beta-mercaptoehtanol, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 278K
|
Resolution 1.80 Å
R-free 0.222
|
|
1ZYT
Crystal structure of spin labeled T4 Lysozyme (A82R1)
Deposited 2005-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/A82C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
AZI AZIDE ION × 1
CL CHLORIDE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;293 K;potassium phosphate, sodium phospahte, sodium choloride, sodium azide, oxidized beta-mercaptoehtanol , pH 6.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.70 Å
R-free 0.206
|
|
200L
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME
Deposited 1995-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L121A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 1.95 Å
|
|
201L
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME
Deposited 1993-10-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
201L
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME
Deposited 1993-10-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
205L
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME
Deposited 1993-10-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
206L
PHAGE T4 LYSOZYME
Deposited 1996-03-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:A42S, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;pH 6.7
|
Resolution 1.75 Å
|
|
209L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, INS(A73-AAA), C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.70 Å
|
|
210L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, DEL(A73), C97A
|
HED 2-HYDROXYETHYL DISULFIDE × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.89 Å
|
|
211L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, INS(E108-A)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
212L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, INS(L164-AAAA)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MUTANT CRYSTALLIZED FROM PEG IN CONTRAST TO L164AAAA WHICH WAS CRYSTALLIZED FROM PHOSPHATE.
|
Resolution 1.76 Å
|
|
213L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, INS(N140-A)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.13 Å
|
|
214L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, INS(R119-A)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.89 Å
|
|
215L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, INS(T115-A)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.96 Å
|
|
216L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1994-05-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
216L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1994-05-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
|
|
217L
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME
Deposited 1993-04-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
218L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, INS(V131-A)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.05 Å
|
|
219L
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME
Deposited 1996-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, INS(L164-AAAA)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MUTANT WAS CRYSTALLIZED FROM PHOSPHATE IN CONTRAST TO L1 64AAA_PEG WHICH WAS CRYSTALLIZED FROM PEG.
|
Resolution 1.66 Å
|
|
220L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M102A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 1.8-2.2M NA/KPO4 PH 6.3-7.1., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.85 Å
|
|
221L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-05-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
222L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M102A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 1.8-2.2M NA/KPO4 PH 6.3-7.1., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.90 Å
|
|
223L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L133G
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 3
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 1.8-2.2M NA/KPO4 PH 6.3-7.1 WITH OXIDIZED/REDUCED BME. CRYSTALS WERE EXPOSED TO BENZENE VAPOR IN A CAPILLARY FOR SEVERAL DAYS AT ROOM TEMPERATURE., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.90 Å
|
|
224L
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME
Deposited 1993-09-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.85 Å
|
|
225L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L133G
|
PXY PARA-XYLENE × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 1.8-2.2M NA/KPO4 PH 6.3-7.1 WITH OXIDIZED/REDUCED BME. CRYSTALS WERE EXPOSED TO P-XYLENE VAPOR IN A CAPILLARY FOR SEVERAL DAYS AT ROOM TEMPERATURE., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.90 Å
|
|
226L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L133G
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 1.8-2.2M NA/KPO4 PH 6.3-7.1 WITH OXIDIZED/REDUCED BME., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.80 Å
|
|
227L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, F104A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 1.8-2.2M NA/KPO4 PH 6.3-7.1. CRYSTALS WERE EXPOSED TO BENZENE VAPOR IN A CAPILLARY FOR SEVERAL DAYS., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 2.00 Å
|
|
228L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, F104A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 1.8-2.2M NA/KPO4 PH 6.3-7.1., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.90 Å
|
|
229L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, R95A, C97A
|
CL CHLORIDE ION × 2
GAI GUANIDINE × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 25 MM HEPES PH 7.5 WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING 0.1 M NACL, 0.1 M KPO4,20% W/V PEG 3350,PH 7.1, 0.25 M GUAD-HCL (LIGAND)., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.80 Å
|
|
230L
T4 LYSOZYME MUTANT M6L
Deposited 1997-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:M6L, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;M6L WAS AT 15MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL. IT WAS DILUTED BY 1/2 WITH A SOLUTION 1.8M IN NA/KPO4 PH 6.9. THIS WAS ALSO THE WELL SOLUTION. HANGING DROP METHODS WERE USED., pH 7.0, vapor diffusion - hanging drop
|
Resolution 1.90 Å
|
|
231L
T4 LYSOZYME MUTANT M106K
Deposited 1997-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M106K
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;M106K WAS AT 19MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL. IT WAS DILUTED BY 1/2 WITH A SOLUTION 1.8M IN NA/KPO4 PH 6.9. THIS WAS ALSO THE WELL SOLUTION. HANGING DROP METHODS WERE USED., pH 7.0, vapor diffusion - hanging drop
|
Resolution 2.50 Å
|
|
232L
T4 LYSOZYME MUTANT M120K
Deposited 1997-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M120K
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;M120K WAS AT 32MG/ML IN A BUFFER CONTAINING 0.1M NA2PO4 PH 6.6, 0.55 M NACL. IT WAS DILUTED BY 1/2 WITH A SOLUTION 2.0M IN NA/KPO4 PH 7.1. THIS WAS ALSO THE WELL SOLUTION. HANGING DROP METHODS WERE USED., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 1.73 Å
|
|
233L
T4 LYSOZYME MUTANT M120L
Deposited 1997-10-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M120L
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.0
|
Resolution 1.90 Å
|
|
234L
T4 LYSOZYME MUTANT M106L
Deposited 1997-10-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M106L
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;pH 7.0
|
Resolution 1.90 Å
|
|
235L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V111A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.90 Å
|
|
236L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, V87A, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.90 Å
|
|
237L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V149A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.70 Å
|
|
238L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V103A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
239L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I17A, C54T, C97A
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
240L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I27A, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.75 Å
|
|
241L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I29A, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.70 Å
|
|
242L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I50A, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.80 Å
|
|
243L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, I58A, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.75 Å
|
|
244L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, I100A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
245L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:M6A, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.80 Å
|
|
246L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, F67A, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.80 Å
|
|
247L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, L84A, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.75 Å
|
|
248L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I27A, I29A, C54T, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.90 Å
|
|
249L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I27A, C54T, I58A, C97A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.90 Å
|
|
250L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I29A, C54T, I58A, C97A,
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 1.80 Å
|
|
251L
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT
Deposited 1997-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L121A, L133A
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.8;pH 6.8
|
Resolution 2.60 Å
|
|
252L
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS
Deposited 1997-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, M102A, M106A
|
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A BUFFER CONTAINING 0.5 M NACL 0.1 M NAPO4 PH 6.5 WAS DILUTED 1/2 WITH A WELL SOLUTION CONTAINING MIXED K/NAPO4 PH 6.3-7.1,1.8-2.2 MOLAR., pH 7.0, vapor diffusion - hanging drop, temperature 277K
|
Resolution 2.10 Å
|
|
253L
LYSOZYME
Deposited 1997-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D20A, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
254L
LYSOZYME
Deposited 1997-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D20S, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
255L
HYDROLASE
Deposited 1997-11-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D20N, C54T, C97A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
256L
BACTERIOPHAGE T4 LYSOZYME
Deposited 1998-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:M6I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
257L
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME
Deposited 1999-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21H,C54T,C97A,T142H
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;CRYSTALS GROWN IN HANGING DROPS AT 4 DEGREES C. PROTEIN 10-20 MG/ML IN A
BUFFER CONTAINING SODIUM PHOSPHATE PH 5.4, 200 MM NACL, WAS DILUTED 1/2 WITH A
WELL SOLUTION CONTAINING 1.8-2.0 M NA/K PHOSPHATE, 200MM NACL, PH 6.5-7.5, AND
5MM OXIDIZED BME 10% V/V ISOPROPANOL,18% W/V PEG 8000, PH 7.5
|
Resolution 1.90 Å
|
|
258L
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME
Deposited 1999-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;pH 7.50
|
Resolution 1.80 Å
|
|
259L
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME
Deposited 1999-02-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,T21H,T142H
|
CL CHLORIDE ION × 2
CO COBALT (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.92 Å
|
|
260L
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME
Deposited 1999-03-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,T21H,T142H
|
CL CHLORIDE ION × 2
NI NICKEL (II) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
|
|
261L
STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN FOLDING
Deposited 1999-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–50(50 aa)
Chain A
51–162(112 aa)
|
Mutation:L39I
Mutation:L39I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;CRYSTALS WERE GROWN FROM 20% POLYETHYLENE GLYCOL 6000, 20% ISOPROPANOL, 50MM
TRIS-HCL PH 7.5
|
Resolution 2.50 Å
|
|
262L
STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN FOLDING
Deposited 1999-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–50(50 aa)
Chain A
51–162(112 aa)
|
Mutation:L39I
Mutation:L39I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;CRYSTALS WERE GROWN FROM 20%
POLYETHYLENE GLYCOL 6000, 20% ISOPROPANOL,
50MM TRIS-HCL PH 7.5
|
Resolution 2.50 Å
|
|
262L
STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN FOLDING
Deposited 1999-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–50(50 aa)
Chain B
51–162(112 aa)
|
Mutation:L39I
Mutation:L39I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;CRYSTALS WERE GROWN FROM 20%
POLYETHYLENE GLYCOL 6000, 20% ISOPROPANOL,
50MM TRIS-HCL PH 7.5
|
Resolution 2.50 Å
|
|
29AJ
Crystal Structure of the human mARC1 M187K variant
Deposited 2026-03-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–159(159 aa)
|
Mutation:M187K
|
MTE PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER × 1
B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
MOO MOLYBDATE ION × 4
EFK oxidanyl(oxidanylidene)molybdenum × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;291 K;100 mM Bis-TRIS propane, 20 mM Na2MoO4, 10 mM TCEP, 27.5 % PEG3350
|
Resolution 1.63 Å
R-free 0.215
|
|
2A4T
Crystal structure of spin labeled T4 Lysozyme (V131R7)
Deposited 2005-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,V131C
|
R7A S-[(4-bromo-1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
AZI AZIDE ION × 1
CL CHLORIDE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;273 K;potassium phosphate, sodium phospahte, sodium choloride, sodium azide, oxidized beta-mercaptoehtanol, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 273K
|
Resolution 1.70 Å
R-free 0.215
|
|
2B6T
T4 Lysozyme mutant L99A at 200 MPa
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2.0 Molar Na/K phosphates, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293, temperature 20K
|
Resolution 2.10 Å
R-free 0.198
|
|
2B6W
T4 Lysozyme mutant L99A at 200 MPa
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.20 Å
R-free 0.208
|
|
2B6X
T4 Lysozyme mutant L99A at 200 MPa
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~ 2.0 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.11 Å
R-free 0.204
|
|
2B6Y
T4 Lysozyme mutant L99A at ambient pressure
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~ 2.0 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.212
|
|
2B6Z
T4 Lysozyme mutant L99A at ambient pressure
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2.0 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.197
|
|
2B70
T4 Lysozyme mutant L99A at ambient pressure
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~ 2.0 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.218
|
|
2B72
T4 Lysozyme mutant L99A at 100 MPa
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~ 2.0 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.212
|
|
2B73
T4 Lysozyme mutant L99A at 100 MPa
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~ 2.0 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.15 Å
R-free 0.219
|
|
2B74
T4 Lysozyme mutant L99A at 100 MPa
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~ 2.0 M Na/K phosphate, 50 mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.232
|
|
2B75
T4 Lysozyme mutant L99A at 150 MPa
Deposited 2005-10-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T,C97A,L99A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2.0 M Na/K phosphate, 50mM beta-mercaptoethanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.214
|
|
2B7X
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2005-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, residues (YTIGIG) inserted after residue G30
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;298 K;Polyehtylene glycol 4000, 50mM Ammonium sulfate, , pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.319
|
|
2B7X
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2005-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:C54T, C97A, residues (YTIGIG) inserted after residue G30
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;298 K;Polyehtylene glycol 4000, 50mM Ammonium sulfate, , pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.319
|
|
2B7X
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2005-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Mutation:C54T, C97A, residues (YTIGIG) inserted after residue G30
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;298 K;Polyehtylene glycol 4000, 50mM Ammonium sulfate, , pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.319
|
|
2B7X
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2005-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Mutation:C54T, C97A, residues (YTIGIG) inserted after residue G30
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;298 K;Polyehtylene glycol 4000, 50mM Ammonium sulfate, , pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.319
|
|
2CUU
Crystal structure of spin labeled T4 Lysozyme (V131R1)
Deposited 2005-05-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/V131
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
AZI AZIDE ION × 1
CL CHLORIDE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;278 K;potassium phosphate, sodium phospahte, sodium choloride, sodium azide, oxidized beta-mercaptoehtanol, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 278K
|
Resolution 1.75 Å
R-free 0.224
|
|
2F2Q
High resolution crystal structure of T4 lysozyme mutant L20R63/A liganded to guanidinium ion
Deposited 2005-11-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I39L, A63R, T65C, A108C
|
CL CHLORIDE ION × 1
GAI GUANIDINE × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;277 K;0.5 mM protein, 1.8 M MIXED POTASSIUM AND SODIUM PHOSPHATE, 0.2 M GUANIDINIUM CHLORIDE, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.50
|
Resolution 1.45 Å
R-free 0.223
|
|
2F32
Xray crystal structure of lysozyme mutant L20/R63A liganded to ethylguanidinium
Deposited 2005-11-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L39I, INS (NAAKSELDKAI -N62), R63A, C65T, C108A
|
BME BETA-MERCAPTOETHANOL × 1
EGD N-ETHYLGUANIDINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;1.8 M MIXED POTASSIUM AND SODIUM PHOSPHATE. 0.2 M ETHYL GUANIDINIUM CHLORIDE, pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.245
|
|
2F47
Xray crystal structure of T4 lysozyme mutant L20/R63A liganded to methylguanidinium
Deposited 2005-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L39I, INS (NAAKSELDKAI -N62), R63A, C65T, C108A
|
CL CHLORIDE ION × 1
MGX 1-METHYLGUANIDINE × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;1.8 M MIXED POTASSIUM AND SODIUM PHOSPHATE. 0.2 M GUANIDINIUM CHLORIDE, pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.70 Å
R-free 0.217
|
|
2HUK
Crystal structure of T4 Lysozyme V131C synthetic dimer
Deposited 2006-07-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
|
Mutation:V131C
|
SO4 SULFATE ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;295 K;20% PEG 8000, 0.1M Na Cacodylate, pH 6.5, 0.2M Ammonium Acetate, VAPOR DIFFUSION, HANGING DROP, temperature 295K, pH 6.50
|
Resolution 2.00 Å
R-free 0.240
|
|
2HUL
Crystal structure of T4 Lysozyme S44C synthetic dimer
Deposited 2006-07-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
|
Mutation:S44C
|
SO4 SULFATE ION × 8
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;298 K;2.0 M Ammonium Sulfate, 0.1 M Cacodylate pH 6.7, 0.2 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 6.70
|
Resolution 1.80 Å
R-free 0.192
|
|
2HUL
Crystal structure of T4 Lysozyme S44C synthetic dimer
Deposited 2006-07-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S44C
|
SO4 SULFATE ION × 4
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;298 K;2.0 M Ammonium Sulfate, 0.1 M Cacodylate pH 6.7, 0.2 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 6.70
|
Resolution 1.80 Å
R-free 0.192
|
|
2HUM
Crystal structure of T4 Lysozyme D72C synthetic dimer
Deposited 2006-07-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
Chain B
1–164(164 aa)
|
Mutation:C54T, D72C, C97A
Mutation:C54T, D72C, C97A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;0.2 M tri-Lithium Citrate, 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.35 Å
R-free 0.304
|
|
2IGC
Structure of Spin labeled T4 Lysozyme Mutant T115R1A
Deposited 2006-09-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;296 K;1.8 M NaH2PO4, 1.8 M K2HPO4, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 1.40 Å
R-free 0.198
|
|
2L78
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME
Deposited 1992-01-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
2LC9
Solution Structure of a Minor and Transiently Formed State of a T4 Lysozyme Mutant
Deposited 2011-04-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A, G113A, R119P
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;307 K;Ionic strength (raw mmCIF value) 85;Pressure ambient
NMR measurement conditions
pH 5.5;308 K;Ionic strength (raw mmCIF value) 85;Pressure ambient
NMR sample composition
1.5 mM [U-100% 13C; U-100% 15N] T4 L99A/G113A/R119P, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2LCB
Solution Structure of a Minor and Transiently Formed State of a T4 Lysozyme Mutant
Deposited 2011-04-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K;Ionic strength (raw mmCIF value) 85;Pressure ambient
NMR sample composition
1.5 mM [U-15N; U-2H] T4 L99A, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.5 mM [U-13C; U-15N; U-2H] T4 L99A, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.5 mM [U-13Ca; U-15N] T4 L99A, 100% D2O | 100% D2O
NMR sample composition
1.5 mM [U-13C; U-15N; U-50% 2H] T4 L99A, 100% D2O | 100% D2O
NMR sample composition
1.5 mM [ U-15N] 13CH3 Met T4 L99A, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2LZM
STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME REFINED AT 1.7 ANGSTROMS RESOLUTION
Deposited 1986-08-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
2NTG
Structure of Spin-labeled T4 Lysozyme Mutant T115R7
Deposited 2006-11-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, T115C
|
R7A S-[(4-bromo-1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;296 K;2.0 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 1.40 Å
R-free 0.210
|
|
2NTH
Structure of Spin-labeled T4 Lysozyme Mutant L118R1
Deposited 2006-11-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;296 K;2.0 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 1.80 Å
R-free 0.212
|
|
2O4W
T4 lysozyme circular permutant
Deposited 2006-12-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
13–164(152 aa)
Chain A
1–12(12 aa)
|
Mutation:C54T, C97A
Mutation:C54T, C97A
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;0.9 M K2HPO4, 1.1 M NaH2PO4, pH 6.9, 0.25 M NaCl, 49.0 mM oxidized B-mercaptoethanol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.213
|
|
2O79
T4 lysozyme with C-terminal extension
Deposited 2006-12-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 3
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;277 K;0.9 M K2HPO4, 1.1 M NaH2PO4, pH 6.6, 0.25 M NaCl, 49.0 mM oxidized B mercaptoethanol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.182
|
|
2O7A
T4 lysozyme C-terminal fragment
Deposited 2006-12-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
60–164(105 aa)
Chain A
1–12(12 aa)
|
Mutation:C97A
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:C97A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACT ACETATE ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;291 K;100 mM NaCacodylate pH 5.0, 200 mM NaAcetate, 26% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 0.84 Å
R-free 0.108
|
|
2OE4
High Pressure Psuedo Wild Type T4 Lysozyme
Deposited 2006-12-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2.0 M NA/K PHOSPHATES, 50 MM BETA-MERCAPTOETHANOL, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.222
|
|
2OE7
High-Pressure T4 Lysozyme
Deposited 2006-12-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2.0 M NA/K PHOSPHATES, 50 MM BETA-MERCAPTOETHANOL, PH 7.1, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
|
Resolution 2.10 Å
R-free 0.214
|
|
2OE9
High-pressure structure of pseudo-WT T4 Lysozyme
Deposited 2006-12-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2.0 M NA/K PHOSPHATES, 50 MM BETA-MERCAPTOETHANOL, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.01 Å
R-free 0.210
|
|
2OEA
High-pressure structure of pseudo-WT T4 Lysozyme
Deposited 2006-12-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;293 K;~2.0 M NA/K PHOSPHATES, 50 MM BETA-MERCAPTOETHANOL, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.01 Å
R-free 0.213
|
|
2OTY
1,2-dichlorobenzene in complex with T4 Lysozyme L99A
Deposited 2007-02-09
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 3
BME BETA-MERCAPTOETHANOL × 1
YAN 1,2-DICHLOROBENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.83 Å
R-free 0.235
|
|
2OTZ
N-methylaniline in complex with T4 Lysozyme L99A
Deposited 2007-02-09
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 2
1MR N-METHYLANILINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.07 Å
R-free 0.258
|
|
2OU0
1-methylpyrrole in complex with T4 Lysozyme L99A
Deposited 2007-02-09
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 2
MR3 1-METHYL-1H-PYRROLE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.94 Å
R-free 0.234
|
|
2OU8
Structure of Spin-labeled T4 Lysozyme Mutant T115R1 at Room Temperature
Deposited 2007-02-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
BME BETA-MERCAPTOETHANOL × 4
|
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;296 K;1.8 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 1.80 Å
R-free 0.238
|
|
2OU9
Structure of Spin-labeled T4 Lysozyme Mutant T115R1/R119A
Deposited 2007-02-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, R119A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.9;296 K;2.0 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.9, VAPOR DIFFUSION, temperature 296K
|
Resolution 1.55 Å
R-free 0.220
|
|
2Q9D
Structure of spin-labeled T4 lysozyme mutant A41R1
Deposited 2007-06-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
BME BETA-MERCAPTOETHANOL × 1
|
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;294 K;2.0 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 1.40 Å
R-free 0.202
|
|
2Q9E
Structure of spin-labeled T4 lysozyme mutant S44R1
Deposited 2007-06-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, N55A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;294 K;2.0 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.10 Å
R-free 0.250
|
|
2Q9E
Structure of spin-labeled T4 lysozyme mutant S44R1
Deposited 2007-06-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:C54T, C97A, N55A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
HED 2-HYDROXYETHYL DISULFIDE × 2
|
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;294 K;2.0 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.10 Å
R-free 0.250
|
|
2Q9E
Structure of spin-labeled T4 lysozyme mutant S44R1
Deposited 2007-06-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Mutation:C54T, C97A, N55A
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
Experimental method not declared
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;294 K;2.0 M Na/K Phosphate, 240 mM NaCl, 40 mM 2-hydroxyethyl disulfide, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.10 Å
R-free 0.250
|
|
2QB0
Structure of the 2TEL crystallization module fused to T4 lysozyme with an Ala-Gly-Pro linker.
Deposited 2007-06-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2–162(161 aa)
|
Not recorded
|
MN MANGANESE (II) ION × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.56 Å
R-free 0.252
|
|
2QB0
Structure of the 2TEL crystallization module fused to T4 lysozyme with an Ala-Gly-Pro linker.
Deposited 2007-06-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–162(161 aa)
|
Not recorded
|
MN MANGANESE (II) ION × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.56 Å
R-free 0.252
|
|
2RAY
beta-chlorophenetole in complex with T4 lysozyme L99A
Deposited 2007-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Mutation:L99A
|
PO4 PHOSPHATE ION × 1
258 (2-chloroethoxy)benzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, hanging drop, temperature 277K
|
Resolution 1.80 Å
R-free 0.212
|
|
2RAZ
4-(methylthio)nitrobenzene in complex with T4 lysozyme L99A
Deposited 2007-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Mutation:L99A
|
PO4 PHOSPHATE ION × 3
259 1-(methylsulfanyl)-4-nitrobenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.64 Å
R-free 0.221
|
|
2RB0
2,6-difluorobenzylbromide complex with T4 lysozyme L99A
Deposited 2007-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Mutation:L99A
|
PO4 PHOSPHATE ION × 2
260 2-(bromomethyl)-1,3-difluorobenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.84 Å
R-free 0.233
|
|
2RB1
2-ethoxyphenol in complex with T4 lysozyme L99A
Deposited 2007-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Mutation:L99A
|
PO4 PHOSPHATE ION × 1
261 2-ethoxyphenol × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.70 Å
R-free 0.230
|
|
2RB2
3-methylbenzylazide in complex with T4 lysozyme L99A
Deposited 2007-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–162(162 aa)
|
Mutation:L99A
|
PO4 PHOSPHATE ION × 3
263 1-(azidomethyl)-3-methylbenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.46 Å
R-free 0.213
|
|
2RBN
N-phenylglycinonitrile in complex with T4 lysozyme L99A/M102Q
Deposited 2007-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:L99A/M102Q
|
PO4 PHOSPHATE ION × 1
264 (phenylamino)acetonitrile × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.29 Å
R-free 0.191
|
|
2RBO
2-nitrothiophene in complex with T4 lysozyme L99A/M102Q
Deposited 2007-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:L99A/M102Q
|
PO4 PHOSPHATE ION × 1
265 2-nitrothiophene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.29 Å
R-free 0.193
|
|
2RBP
2-(n-propylthio)ethanol in complex with T4 lysozyme L99A/M102Q
Deposited 2007-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:L99A/M102Q
|
PO4 PHOSPHATE ION × 1
266 2-(propylsulfanyl)ethanol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.47 Å
R-free 0.206
|
|
2RBQ
3-methylbenzylazide in complex with T4 L99A/M102Q
Deposited 2007-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:L99A/M102Q
|
PO4 PHOSPHATE ION × 1
263 1-(azidomethyl)-3-methylbenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.63 Å
R-free 0.240
|
|
2RBR
2-phenoxyethanol in complex with T4 lysozyme L99A/M102Q
Deposited 2007-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:L99A/M102Q
|
PO4 PHOSPHATE ION × 1
268 2-phenoxyethanol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.43 Å
R-free 0.200
|
|
2RBS
(r)(+)-3-chloro-1-phenyl-1-propanol in complex with T4 lysozyme L99A/M102Q
Deposited 2007-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:L99A/M102Q
|
PO4 PHOSPHATE ION × 2
269 (1R)-3-chloro-1-phenylpropan-1-ol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 7.1, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.56 Å
R-free 0.205
|
|
2RH1
High resolution crystal structure of human B2-adrenergic G protein-coupled receptor.
Deposited 2007-10-05
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:N187E, C54T, C97A
|
SO4 SULFATE ION × 6
CAU (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol × 1
BU1 1,4-BUTANEDIOL × 2
ACM ACETAMIDE × 1
CLR CHOLESTEROL × 3
PLM PALMITIC ACID × 1
12P DODECAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC MESOPHASE;pH 6.75;293 K;30-35% v/v PEG 400, 0.1-0.2 M Na2SO4, 0.1 M Bis-tris propane pH 6.5-7.0, 5-7% 1,4-Butanediol, 8-10% Cholesterol, 52-50% Monoolein, pH 6.75, LIPIDIC MESOPHASE, temperature 293K
|
Resolution 2.40 Å
R-free 0.232
|
|
3C7W
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme
Deposited 2008-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96K
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7, 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K, pH 6.70
|
Resolution 1.77 Å
R-free 0.187
|
|
3C7Y
Mutant R96A OF T4 lysozyme in wildtype background at 298K
Deposited 2008-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96A
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;2 M NA/K PHOSPHATE PH 6.7
550 mM NACL
50 MM REDUCED BME,
50 MM OXIDIZED BME
, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.95 Å
|
|
3C7Z
T4 lysozyme mutant D89A/R96H at room temperature
Deposited 2008-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D89A,R96H
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K, pH 6.70
|
Resolution 1.67 Å
|
|
3C80
T4 Lysozyme mutant R96Y at room temperature
Deposited 2008-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.99 Å
|
|
3C81
Mutant K85A of T4 lysozyme in wildtype background at room temperature
Deposited 2008-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:K85A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.85 Å
|
|
3C82
Bacteriophage lysozyme T4 lysozyme mutant K85A/R96H
Deposited 2008-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:K85A,R96H
|
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.68 Å
|
|
3C83
Bacteriophage T4 lysozyme mutant D89A in wildtype background at room temperature
Deposited 2008-02-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D89A
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.84 Å
|
|
3C8Q
Contribution of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme
Deposited 2008-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96D
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2M NA/K PHOSPHATE PH 6.7, 50 MM OXIDIZED BME, 50 MM REDUCED BME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 276K, pH 6.70
|
Resolution 1.64 Å
R-free 0.186
|
|
3C8R
Contributions of all 20 amino acids at site 96 to stability and structure of T4 lysozyme
Deposited 2008-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96G
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2M NA/K PHOSPHATE 50 MM REDUCED BME 50 MM OXIDIZED BME, PH 6.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 276K, PH 6.70
|
Resolution 1.80 Å
R-free 0.172
|
|
3C8S
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme
Deposited 2008-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96E
|
CL CHLORIDE ION × 2
K POTASSIUM ION × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7 50 MM REDUCED BME 50 MM OXIDIZED BME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.68 Å
R-free 0.204
|
|
3CDO
Bacteriophage T4 lysozyme mutant R96V in wildtype background at low temperature
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96V
|
HEZ HEXANE-1,6-DIOL × 1
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;100 MM MES, 200 MM LITHIUM SULFATE, 35% MPD, 50 MM 1,6-HEXANEDIOL, 12.5 MG/ML, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.00
|
Resolution 1.87 Å
R-free 0.231
|
|
3CDO
Bacteriophage T4 lysozyme mutant R96V in wildtype background at low temperature
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:R96V
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;100 MM MES, 200 MM LITHIUM SULFATE, 35% MPD, 50 MM 1,6-HEXANEDIOL, 12.5 MG/ML, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.00
|
Resolution 1.87 Å
R-free 0.231
|
|
3CDO
Bacteriophage T4 lysozyme mutant R96V in wildtype background at low temperature
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Mutation:R96V
|
HEZ HEXANE-1,6-DIOL × 2
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;100 MM MES, 200 MM LITHIUM SULFATE, 35% MPD, 50 MM 1,6-HEXANEDIOL, 12.5 MG/ML, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.00
|
Resolution 1.87 Å
R-free 0.231
|
|
3CDO
Bacteriophage T4 lysozyme mutant R96V in wildtype background at low temperature
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Mutation:R96V
|
HEZ HEXANE-1,6-DIOL × 1
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;100 MM MES, 200 MM LITHIUM SULFATE, 35% MPD, 50 MM 1,6-HEXANEDIOL, 12.5 MG/ML, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.00
|
Resolution 1.87 Å
R-free 0.231
|
|
3CDQ
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96S
|
CL CHLORIDE ION × 2
K POTASSIUM ION × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7 50 MM REDUCED BME 50 MM OXIDIZED BME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.68 Å
R-free 0.196
|
|
3CDR
R96Q Mutant of wildtype phage T4 lysozyme at 298 K
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96Q
|
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7, 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.70 Å
|
|
3CDT
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96N
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7, 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.63 Å
R-free 0.195
|
|
3CDV
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme
Deposited 2008-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96M
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.7;2 M NA/K PHOSPHATE PH 6.7, 550 MM NACL 50 MM REDUCED BME, 50 MM OXIDIZED BME , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, pH 6.70
|
Resolution 1.73 Å
R-free 0.200
|
|
3D4S
Cholesterol bound form of human beta2 adrenergic receptor.
Deposited 2008-05-14
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:E122W, N187E, C1054T, C1097A
|
TIM (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol × 1
CLR CHOLESTEROL × 2
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MESOPHASE;pH 7;293 K;28% v/v PEG 400, 300mM K formate, 100mM Bis-tris propane pH 7.0, 2mM Timolol, MESOPHASE, temperature 293K
|
Resolution 2.80 Å
R-free 0.273
|
|
3DKE
Polar and non-polar cavities in phage T4 lysozyme
Deposited 2008-06-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–164(164 aa)
|
Mutation:C54T, C97A, L99A, M102L
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
K POTASSIUM ION × 1
CL CHLORIDE ION × 2
AZI AZIDE ION × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
BME BETA-MERCAPTOETHANOL × 2
HED 2-HYDROXYETHYL DISULFIDE × 2
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M NaH2PO4 and K2HPO4, pH 6.9, 5mM BME, 5mM oxidized BME, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.25 Å
R-free 0.173
|
|
3DMV
Free of ligand binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 3
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were made by soaking or gas-phase diffusion, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.65 Å
R-free 0.210
|
|
3DMX
Benzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 2
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.208
|
|
3DMZ
Hexafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
CL CHLORIDE ION × 1
HFB hexafluorobenzene × 1
HED 2-HYDROXYETHYL DISULFIDE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å
R-free 0.214
|
|
3DN0
Pentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
CL CHLORIDE ION × 1
F5B 1,2,3,4,5-pentafluorobenzene × 1
HED 2-HYDROXYETHYL DISULFIDE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME
Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.222
|
|
3DN1
Chloropentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
CL CHLORIDE ION × 1
BCF 1-chloro-2,3,4,5,6-pentafluorobenzene × 1
HED 2-HYDROXYETHYL DISULFIDE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.220
|
|
3DN2
Bromopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
BBF 1-bromo-2,3,4,5,6-pentafluorobenzene × 1
HED 2-HYDROXYETHYL DISULFIDE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.215
|
|
3DN3
Iodopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
IBF 1,2,3,4,5-pentafluoro-6-iodobenzene × 1
HED 2-HYDROXYETHYL DISULFIDE × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.210
|
|
3DN4
Iodobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
PIH iodobenzene × 1
HED 2-HYDROXYETHYL DISULFIDE × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.223
|
|
3DN6
1,3,5-trifluoro-2,4,6-trichlorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
|
PO4 PHOSPHATE ION × 2
F3B 1,3,5-trichloro-2,4,6-trifluorobenzene × 1
HED 2-HYDROXYETHYL DISULFIDE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.221
|
|
3DN8
Iodopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant (seleno version)
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A, seleno version
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 3
BME BETA-MERCAPTOETHANOL × 1
IBF 1,2,3,4,5-pentafluoro-6-iodobenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.70 Å
R-free 0.223
|
|
3DNA
Iodobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant (seleno version)
Deposited 2008-07-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L99A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 3
BME BETA-MERCAPTOETHANOL × 1
PIH iodobenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2 M K/Na phosphate, pH 6.9, 5mM BME and 5mM oxidized BME. Complexes were prepared by soaking or vapor diffusion methods, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.70 Å
R-free 0.217
|
|
3EML
The 2.6 A Crystal Structure of a Human A2A Adenosine Receptor bound to ZM241385.
Deposited 2008-09-24
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
ZMA 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol × 1
STE STEARIC ACID × 5
SO4 SULFATE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;293 K;PEG400 30%v/v, LiSO4 185mM, NaCitrate 100mM, pH 6.5, Lipidic mesophase, temperature 293K
|
Resolution 2.60 Å
R-free 0.231
|
|
3F8V
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T4 Lysozyme Mutant Arg96-->His
Deposited 2008-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96H
|
HED 2-HYDROXYETHYL DISULFIDE × 1
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 2
NA SODIUM ION × 1
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.3;277 K;2 M Na/K Phosphate, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.08 Å
R-free 0.163
|
|
3F9L
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T4 Lysozyme Mutant Arg96-->His
Deposited 2008-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D72A
|
PO4 PHOSPHATE ION × 1
NA SODIUM ION × 1
CL CHLORIDE ION × 2
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;2M Na/K Phosphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.19 Å
R-free 0.189
|
|
3FA0
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T4 Lysozyme Mutant Arg96-->His
Deposited 2008-11-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Not recorded
|
HED 2-HYDROXYETHYL DISULFIDE × 1
BME BETA-MERCAPTOETHANOL × 1
PO4 PHOSPHATE ION × 2
CL CHLORIDE ION × 2
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;2 M Na/K phosphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.09 Å
R-free 0.188
|
|
3FAD
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T4 Lysozyme Mutant Arg96-->His
Deposited 2008-11-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:D72A/R96H
|
PO4 PHOSPHATE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;2 M Na/K Phospahte, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.20 Å
R-free 0.174
|
|
3FAD
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T4 Lysozyme Mutant Arg96-->His
Deposited 2008-11-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
|
Mutation:D72A/R96H
|
PO4 PHOSPHATE ION × 4
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;277 K;2 M Na/K Phospahte, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.20 Å
R-free 0.174
|
|
3FI5
Crystal Structure of T4 Lysozyme Mutant R96W
Deposited 2008-12-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R96W
|
CL CHLORIDE ION × 1
NA SODIUM ION × 1
IPA ISOPROPYL ALCOHOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.53 Å
R-free 0.261
|
|
3FI5
Crystal Structure of T4 Lysozyme Mutant R96W
Deposited 2008-12-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:R96W
|
CL CHLORIDE ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.53 Å
R-free 0.261
|
|
3FI5
Crystal Structure of T4 Lysozyme Mutant R96W
Deposited 2008-12-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Mutation:R96W
|
CL CHLORIDE ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.53 Å
R-free 0.261
|
|
3FI5
Crystal Structure of T4 Lysozyme Mutant R96W
Deposited 2008-12-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Mutation:R96W
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.53 Å
R-free 0.261
|
|
3G3V
Crystal structure of spin labeled T4 Lysozyme (V131R1) at 291 K
Deposited 2009-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V131C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
AZI AZIDE ION × 1
CL CHLORIDE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;278 K;2.0M dibasic potassium phosphate and monobasic sodium phospahte, 0.25M sodium choloride, 0.04% sodium azide, 0.02M oxidized beta-mercaptoehtanol, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 278K
|
Resolution 2.10 Å
R-free 0.199
|
|
3G3W
Crystal structure of spin labeled T4 Lysozyme (T151R1) at 291 K
Deposited 2009-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, T151C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
CL CHLORIDE ION × 1
AZI AZIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;278 K;2.0M dibasic potassium phosphate and monobasic sodium phospahte, 0.25M sodium choloride, 0.04% sodium azide, 0.02M oxidized beta-mercaptoehtanol, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 278K
|
Resolution 2.30 Å
R-free 0.216
|
|
3G3X
Crystal structure of spin labeled T4 Lysozyme (T151R1) at 100 K
Deposited 2009-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, T151R1
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
AZI AZIDE ION × 2
CL CHLORIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;278 K;2.0M dibasic potassium phosphate and monobasic sodium phospahte, 0.25M sodium choloride, 0.04% sodium azide, 0.02M oxidized beta-mercaptoehtanol, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 278K
|
Resolution 1.80 Å
R-free 0.224
|
|
3GUI
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Apo structure
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
BME BETA-MERCAPTOETHANOL × 1
CO3 CARBONATE ION × 1
TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;30% PEG 8000, 0.20M ammonium sulfate, 0.10M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.45 Å
R-free 0.206
|
|
3GUJ
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Benzene binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
BNZ BENZENE × 1
BME BETA-MERCAPTOETHANOL × 1
CO3 CARBONATE ION × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;30% PEG 8000, 0.2M ammounium sulfate, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.60 Å
R-free 0.239
|
|
3GUK
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Toluene binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MBN TOLUENE × 1
CA CALCIUM ION × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.85 Å
R-free 0.273
|
|
3GUK
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Toluene binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MBN TOLUENE × 1
CL CHLORIDE ION × 1
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.85 Å
R-free 0.273
|
|
3GUL
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--ethylbenzene binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PYJ PHENYLETHANE × 1
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.07 Å
R-free 0.293
|
|
3GUL
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--ethylbenzene binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PYJ PHENYLETHANE × 1
CA CALCIUM ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.07 Å
R-free 0.293
|
|
3GUM
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--p-xylene binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PXY PARA-XYLENE × 1
CL CHLORIDE ION × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.24 Å
R-free 0.264
|
|
3GUM
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--p-xylene binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PXY PARA-XYLENE × 1
CL CHLORIDE ION × 2
ACT ACETATE ION × 1
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.24 Å
R-free 0.264
|
|
3GUN
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--aniline binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ANL ANILINE × 2
CA CALCIUM ION × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.50 Å
R-free 0.251
|
|
3GUN
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--aniline binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ANL ANILINE × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.50 Å
R-free 0.251
|
|
3GUO
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--phenol binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
IPH PHENOL × 1
CL CHLORIDE ION × 1
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.16 Å
R-free 0.272
|
|
3GUO
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--phenol binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
IPH PHENOL × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.16 Å
R-free 0.272
|
|
3GUP
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--pyridine binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
0PY pyridine × 2
CO3 CARBONATE ION × 1
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.50 Å
R-free 0.253
|
|
3GUP
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--pyridine binding
Deposited 2009-03-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102E/E108V/S117V/T142C/N144D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
0PY pyridine × 1
CO3 CARBONATE ION × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;30% PEG 8000, 0.14M magnesium/calcium sulfate, 0.1M PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.50 Å
R-free 0.253
|
|
3HH3
New azaborine compounds bind to the T4 lysozyme L99A cavity - 1,2-dihydro-1,2-azaborine
Deposited 2009-05-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,L99A
|
HED 2-HYDROXYETHYL DISULFIDE × 2
PO4 PHOSPHATE ION × 1
NA SODIUM ION × 1
B20 1,2-dihydro-1,2-azaborinine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2M K/Na phosphase, 50mM BME, 50mM HED (vapor-diffusion for complex preparation), pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.25 Å
R-free 0.187
|
|
3HH4
New azaborine compounds bind to the T4 lysozyme L99A cavity - Benzene as control
Deposited 2009-05-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,L99A
|
HED 2-HYDROXYETHYL DISULFIDE × 2
PO4 PHOSPHATE ION × 1
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2M K/Na phosphase, 50mM BME, 50mM HED (vapor-diffusion for complex preparation), pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.25 Å
R-free 0.192
|
|
3HH5
New azaborine compounds bind to the T4 lysozyme L99A cavity - 1-ethyl-2-hydro-1,2-azaborine
Deposited 2009-05-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T/C97A/L99A
|
HED 2-HYDROXYETHYL DISULFIDE × 1
NA SODIUM ION × 1
PO4 PHOSPHATE ION × 1
B24 1-ethyl-1,2-dihydro-1,2-azaborinine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2M K/Na phosphase, 50mM BME, 50mM HED (vapor-diffusion for complex preparation), pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.25 Å
R-free 0.182
|
|
3HH6
New azaborine compounds bind to the T4 lysozyme L99A cavity -ethylbenzene as control
Deposited 2009-05-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,L99A
|
HED 2-HYDROXYETHYL DISULFIDE × 2
PO4 PHOSPHATE ION × 1
PYJ PHENYLETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277 K;2.0-2.2M K/Na phosphase, 50mM BME, 50mM HED (vapor-diffusion for complex preparation), pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.25 Å
R-free 0.182
|
|
3HT6
2-methylphenol in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A, M102Q,N144D
|
PO4 PHOSPHATE ION × 2
JZ0 o-cresol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.59 Å
R-free 0.220
|
|
3HT7
2-ethylphenol in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 2
JZ1 2-ethylphenol × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.70 Å
R-free 0.222
|
|
3HT8
5-chloro-2-methylphenol in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 2
JZ2 5-chloro-2-methylphenol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.60 Å
R-free 0.214
|
|
3HT9
2-methoxyphenol in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 2
JZ3 Guaiacol × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 2.02 Å
R-free 0.219
|
|
3HTB
2-propylphenol in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 2
JZ4 2-propylphenol × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.81 Å
R-free 0.245
|
|
3HTD
(Z)-Thiophene-2-carboxaldoxime in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 1
JZ5 (NZ)-N-(thiophen-2-ylmethylidene)hydroxylamine × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.40 Å
R-free 0.190
|
|
3HTF
4-chloro-1h-pyrazole in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 1
JZ6 4-chloro-1H-pyrazole × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.85 Å
R-free 0.208
|
|
3HTG
2-ethoxy-3,4-dihydro-2h-pyran in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 1
BME BETA-MERCAPTOETHANOL × 1
JZ7 (2S)-2-ethoxy-3,4-dihydro-2H-pyran × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.26 Å
R-free 0.181
|
|
3HU8
2-ethoxyphenol in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 2
261 2-ethoxyphenol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.80 Å
R-free 0.213
|
|
3HU9
Nitrosobenzene in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 1
NBE NITROSOBENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.46 Å
R-free 0.202
|
|
3HUA
4,5,6,7-tetrahydroindole in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S44D,L99A,M102Q,N144D
|
JZ9 4,5,6,7-tetrahydro-1H-indole × 1
BME BETA-MERCAPTOETHANOL × 2
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.40 Å
R-free 0.192
|
|
3HUK
Benzylacetate in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 1
J0Z benzyl acetate × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.29 Å
R-free 0.185
|
|
3HUQ
Thieno[3,2-b]thiophene in complex with T4 lysozyme L99A/M102Q
Deposited 2009-06-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:S38D,L99A,M102Q,N144D
|
PO4 PHOSPHATE ION × 1
J1Z thieno[3,2-b]thiophene × 1
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;2.2M sodium-potassium phosphate, 0.05M beta-mercaptoethanol, 0.05M 2-hydroxyethyldisulfide, pH 6.5, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.45 Å
R-free 0.189
|
|
3HWL
Crystal Structure of T4 lysozyme with the unnatural amino acid p-Acetyl-L-Phenylalanine incorporated at position 131
Deposited 2009-06-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,C97A,N68C,A93C,V131(4AF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
AZI AZIDE ION × 4
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;2.0M sodium/potassium phosphate, 0.2M sodium chloride, 0.04% sodium azide, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.80 Å
R-free 0.227
|
|
3JR6
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2009-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, insertion of seuqence (gighll) after residue L33
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;20% PEG 3400, 50 mM ammonium sulfate, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.320
|
|
3JR6
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2009-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:C54T, C97A, insertion of seuqence (gighll) after residue L33
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;20% PEG 3400, 50 mM ammonium sulfate, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.320
|
|
3JR6
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2009-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–164(164 aa)
|
Mutation:C54T, C97A, insertion of seuqence (gighll) after residue L33
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;20% PEG 3400, 50 mM ammonium sulfate, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.320
|
|
3JR6
Sequential reorganization of beta-sheet topology by insertion of a single strand
Deposited 2009-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–164(164 aa)
|
Mutation:C54T, C97A, insertion of seuqence (gighll) after residue L33
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;20% PEG 3400, 50 mM ammonium sulfate, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.320
|
|
3K2R
Crystal Structure of Spin Labeled T4 Lysozyme Mutant K65V1/R76V1
Deposited 2009-09-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T,K65C,R76C,C97A
|
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 2
HEZ HEXANE-1,6-DIOL × 2
CL CHLORIDE ION × 2
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;2.2M dibasic potassium phosphate and monobasic sodium phosphate, 0.15M sodium chloride, 100mM 1,6 hexanediol, pH 7.0, vapor diffusion, hanging drop, temperature 293K
|
Resolution 1.50 Å
R-free 0.212
|
|
3L2X
Crystal Structure of Spin Labeled T4 Lysozyme Mutant 115-119RX
Deposited 2009-12-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, T115C, R119C
|
RXR [2,2,5,5-tetramethyl-3,4-bis(sulfanylmethyl)-2,5-dihydro-1H-pyrrol-1-yl]oxidanyl radical × 1
AZI AZIDE ION × 1
CL CHLORIDE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;277 K;2.0M dibasic potassium phosphate and monobasic sodium phosphate, 0.25M sodium chloride,
0.04% sodium azide, saturated with bis(2-hydroxyethyl) disulfide, pH 6.4, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.80 Å
R-free 0.232
|
|
3L64
T4 Lysozyme S44E/WT*
Deposited 2009-12-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:S44E, C54T, C97A
|
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;10 Ul of protein solution (20 mg/ml) mixed with 10 Ul of well solution, typically 2.0 M-phosphate (pH 6.3 to 7.1), 0.25 M-NaCl and 6 Ul of 2-hydroxyethyl disulfide/ml (i.e. oxidized beta-mercaptoethanol). The drop was then equilibrated over 1 ml of well solution using a Limbro plate, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.90 Å
|
|
3LZM
STRUCTURAL STUDIES OF MUTANTS OF T4 LYSOZYME THAT ALTER HYDROPHOBIC STABILIZATION
Deposited 1989-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
3NY8
Crystal structure of the human beta2 adrenergic receptor in complex with the inverse agonist ICI 118,551
Deposited 2010-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:Chimeric protein of Beta-2 Adrenoreceptor 1-230, Lysozyme 2-161, Beta-2 adrenergic receptor 263-348
|
Mutation:E122W, N187E, C1054T, C1097A
|
CLR CHOLESTEROL × 2
JRZ (2S,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]butan-2-ol × 1
OLA OLEIC ACID × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
PGE TRIETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
293 K;100 mM Tris/HCl pH 7.5-8.0, 200-500 mM Na-formate, 5% 1,4 butanediol, 27-32% PEG 400, Lipidic Cubic Phase (LCP) Crystallization, temperature 293-295K
|
Resolution 2.84 Å
R-free 0.291
|
|
3NY9
Crystal structure of the human beta2 adrenergic receptor in complex with a novel inverse agonist
Deposited 2010-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:Chimeric protein of Beta-2 Adrenoreceptor 1-230, Lysozyme 2-161, Beta-2 adrenergic receptor 263-348
|
Mutation:E122W, N187E, C1054T, C1097A
|
CLR CHOLESTEROL × 2
JSZ ethyl 4-({(2S)-2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)-3-methyl-1-benzofuran-2-carboxylate × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
293 K;100 mM Tris/HCl pH 7.5-8, 5% 1,4 butanediol, 220 mM Na-formate, 27% PEG 400, Lipidic Cubic Phase (LCP) Crystallization, temperature 293-295K
|
Resolution 2.84 Å
R-free 0.278
|
|
3NYA
Crystal structure of the human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol
Deposited 2010-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:Chimeric protein of Beta-2 Adrenoreceptor 1-230, Lysozyme 2-161, Beta-2 adrenergic receptor 263-348
|
Mutation:E122W, N187E, C1054T, C1097A
|
CLR CHOLESTEROL × 2
JTZ (2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylphenoxy)propan-2-ol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
293 K;100 mM Bis-Tris Propane pH 6.6-6.8, 120 mM Na-tartrate, 3% 1,3 butanediol, 25-30% PEG 400, Lipidic Cubic Phase (LCP) Crystallization, temperature 293-295K
|
Resolution 3.16 Å
R-free 0.290
|
|
3ODU
The 2.5 A structure of the CXCR4 chemokine receptor in complex with small molecule antagonist IT1t
Deposited 2010-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
Chain B
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
|
Mutation:L125W, C1054T, C1097T
Mutation:L125W, C1054T, C1097T
|
ITD (6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate × 2
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 5
OLA OLEIC ACID × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5.5;293 K;Lipidic cubic phase made of monoolein and cholesterol, 20% PEG400, 0.3M Sodium malonate, 5mM Taurine, 0.1M Sodium citrate, pH 5.5, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 2.50 Å
R-free 0.282
|
|
3OE0
Crystal structure of the CXCR4 chemokine receptor in complex with a cyclic peptide antagonist CVX15
Deposited 2010-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1002–1161(160 aa)
Fragment:CXCR4 residues 2-228, LYSOZYME residues 1002-1161, CXCR4 residues 231-319
|
Mutation:L125W, T240P, C1054T, C1097T
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7;293 K;Lipidic cubic phase made of monoolein and cholesterol, 25% PEG400, 0.3M Potassium sodium tartrate, 0.1 M Tris pH 7.0, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 2.90 Å
R-free 0.267
|
|
3OE6
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t in I222 spacegroup
Deposited 2010-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1002–1161(160 aa)
Fragment:CXCR4 residues 2-228, LYSOZYME residues 1002-1161, CXCR4 residues 231-325
|
Mutation:L125W, C1054T, C1097T
|
ITD (6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate × 2
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 6
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5.5;293 K;Lipidic cubic phase made of monoolein and cholesterol, 20-26% PEG400, 0.3M Sodium malonate, 5mM Nickel chloride, 0.1M Sodium citrate pH 5.0-5.5, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 3.20 Å
R-free 0.306
|
|
3OE8
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t in P1 spacegroup
Deposited 2010-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
Chain C
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
|
Mutation:L125W, C1054T, C1097T
Mutation:L125W, C1054T, C1097T
|
ITD (6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;Lipidic cubic phase made of monoolein and cholesterol, 26% PEG400, 0.3M Sodium malonate, 5mM Strontium chloride, 0.1M MES pH 6.0, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 3.10 Å
R-free 0.295
|
|
3OE8
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t in P1 spacegroup
Deposited 2010-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
Chain B
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
Chain C
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
|
Mutation:L125W, C1054T, C1097T
Mutation:L125W, C1054T, C1097T
Mutation:L125W, C1054T, C1097T
|
ITD (6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;Lipidic cubic phase made of monoolein and cholesterol, 26% PEG400, 0.3M Sodium malonate, 5mM Strontium chloride, 0.1M MES pH 6.0, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 3.10 Å
R-free 0.295
|
|
3OE8
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t in P1 spacegroup
Deposited 2010-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1002–1161(160 aa)
Fragment:CXCR4 residues 2-229, LYSOZYME residues 1002-1161, CXCR4 residues 230-319
|
Mutation:L125W, C1054T, C1097T
|
ITD (6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;Lipidic cubic phase made of monoolein and cholesterol, 26% PEG400, 0.3M Sodium malonate, 5mM Strontium chloride, 0.1M MES pH 6.0, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 3.10 Å
R-free 0.295
|
|
3OE9
Crystal structure of the chemokine CXCR4 receptor in complex with a small molecule antagonist IT1t in P1 spacegroup
Deposited 2010-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1002–1161(160 aa)
Fragment:CXCR4 residues 2-228, LYSOZYME residues 1002-1161, CXCR4 residues 231-319
Chain B
1002–1161(160 aa)
Fragment:CXCR4 residues 2-228, LYSOZYME residues 1002-1161, CXCR4 residues 231-319
|
Mutation:L125W, T240P, C1054T, C1097T
Mutation:L125W, T240P, C1054T, C1097T
|
ITD (6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;Lipidic cubic phase made of monoolein and cholesterol, 27-35% PEG400, 0.27-0.33M Sodium malonate, 5mM Hexamine cobalt chloride, 0.1M MES pH 6.0, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 3.10 Å
R-free 0.284
|
|
3P0G
Structure of a nanobody-stabilized active state of the beta2 adrenoceptor
Deposited 2010-09-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP P07550 residues 1-230, 263-365, UNP P00720 residues 2-161
|
Mutation:N187E
|
P0G 8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;293 K;36-44% PEG 400, 100 mM Tris pH 8.0, 4% DMSO, 1% 1,2,3-heptanetriol, twin-syringe mixing method, temperature 293K
|
Resolution 3.50 Å
R-free 0.308
|
|
3PBL
Structure of the human dopamine D3 receptor in complex with eticlopride
Deposited 2010-10-20
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:L119W, C1054T, C1097A
|
ETQ 3-chloro-5-ethyl-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-6-hydroxy-2-methoxybenzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.5;293 K;Lipidic cubic phase made of monoolein and 10% cholesterol, 30% PEG400, 300mM Ammonium acetate, 2% glucose, 100mM bis tris propane pH 7.5, 1mM eticlopride, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 2.89 Å
R-free 0.272
|
|
3PBL
Structure of the human dopamine D3 receptor in complex with eticlopride
Deposited 2010-10-20
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Mutation:L119W, C1054T, C1097A
|
ETQ 3-chloro-5-ethyl-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-6-hydroxy-2-methoxybenzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.5;293 K;Lipidic cubic phase made of monoolein and 10% cholesterol, 30% PEG400, 300mM Ammonium acetate, 2% glucose, 100mM bis tris propane pH 7.5, 1mM eticlopride, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 2.89 Å
R-free 0.272
|
|
3PDS
Irreversible Agonist-Beta2 Adrenoceptor Complex
Deposited 2010-10-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–162(161 aa)
|
Mutation:H93C,N187E,C265A
|
ERC 8-hydroxy-5-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(3-sulfanylpropoxy)phenyl]ethyl}amino)ethyl]quinolin-2(1H)-one × 1
CLR CHOLESTEROL × 1
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.7;293 K;26 %(v/v) PEG 400, 200 mM Li2SO4, 4 %(v/v) DMSO, 3.5 %(v/v) 1,4-butandediol, 100 mM MES pH 6.7, Lipidic Cubic Phase, temperature 293K
|
Resolution 3.50 Å
R-free 0.283
|
|
3QAK
Agonist bound structure of the human adenosine A2a receptor
Deposited 2011-01-11
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
UKA 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG400 30%v/v, MgCl2 200mM, pH 5.0, Lipidic cubic phase, temperature 293K
|
Resolution 2.71 Å
R-free 0.273
|
|
3RUN
New strategy to analyze structures of glycopeptide antibiotic-target complexes
Deposited 2011-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, L164A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 2
PO4 PHOSPHATE ION × 1
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
CL CHLORIDE ION × 1
IPA ISOPROPYL ALCOHOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;291 K;0.2M ammonium phosphate, 0.1M Tris 8.5, 35% MPD, vapor diffusion, hanging drop, temperature 291K
|
Resolution 1.40 Å
R-free 0.180
|
|
3RZE
Structure of the human histamine H1 receptor in complex with doxepin
Deposited 2011-05-11
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
5EH (3E)-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine × 1
D7V (3Z)-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine × 1
PO4 PHOSPHATE ION × 3
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.5;293 K;26-30% PEG400, 300mM ammonium phosphate, 10mM MgCl2, 100mM Na-citrate pH 4.5, 1mM doxepin, Lipidic cubic phase, 293K
|
Resolution 3.10 Å
R-free 0.249
|
|
3SB5
Zn-mediated Trimer of T4 Lysozyme R125C/E128C by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–162(162 aa)
|
Mutation:C54T, C97A, R125C, E128C
|
ZN ZINC ION × 6
CL CHLORIDE ION × 6
MG MAGNESIUM ION × 6
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;290 K;0.2M Magnesium Chloride, 20% PEG 8000, 0.1M TRIS, pH 8.5, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.46 Å
R-free 0.230
|
|
3SB5
Zn-mediated Trimer of T4 Lysozyme R125C/E128C by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–162(162 aa)
|
Mutation:C54T, C97A, R125C, E128C
|
ZN ZINC ION × 6
CL CHLORIDE ION × 6
MG MAGNESIUM ION × 6
GOL GLYCEROL × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;290 K;0.2M Magnesium Chloride, 20% PEG 8000, 0.1M TRIS, pH 8.5, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.46 Å
R-free 0.230
|
|
3SB5
Zn-mediated Trimer of T4 Lysozyme R125C/E128C by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–162(162 aa)
|
Mutation:C54T, C97A, R125C, E128C
|
ZN ZINC ION × 6
CL CHLORIDE ION × 6
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;290 K;0.2M Magnesium Chloride, 20% PEG 8000, 0.1M TRIS, pH 8.5, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.46 Å
R-free 0.230
|
|
3SB5
Zn-mediated Trimer of T4 Lysozyme R125C/E128C by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–162(162 aa)
|
Mutation:C54T, C97A, R125C, E128C
|
ZN ZINC ION × 6
CL CHLORIDE ION × 6
MG MAGNESIUM ION × 6
GOL GLYCEROL × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;290 K;0.2M Magnesium Chloride, 20% PEG 8000, 0.1M TRIS, pH 8.5, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.46 Å
R-free 0.230
|
|
3SB6
Cu-mediated Dimer of T4 Lysozyme D61H/K65H/R76H/R80H by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–162(162 aa)
Chain B
1–162(162 aa)
|
Mutation:C54T, D61H, K65H, R76H, R80H, C97A
Mutation:C54T, D61H, K65H, R76H, R80H, C97A
|
CU COPPER (II) ION × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;0.2M Ammonium Nitrate, 20% PEG 3350, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.70 Å
R-free 0.272
|
|
3SB7
Cu-mediated Trimer of T4 Lysozyme D61H/K65H/R76H/R80H by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–162(162 aa)
|
Mutation:C54T, D61H, K65H, R76H, R80H, C97A
|
CU COPPER (II) ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;0.2M Potassium Thiocyanate, 25% PEG 3350, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.70 Å
R-free 0.226
|
|
3SB7
Cu-mediated Trimer of T4 Lysozyme D61H/K65H/R76H/R80H by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–162(162 aa)
Chain B
1–162(162 aa)
|
Mutation:C54T, D61H, K65H, R76H, R80H, C97A
Mutation:C54T, D61H, K65H, R76H, R80H, C97A
|
GOL GLYCEROL × 1
CU COPPER (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;0.2M Potassium Thiocyanate, 25% PEG 3350, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.70 Å
R-free 0.226
|
|
3SB8
Cu-mediated Dimer of T4 Lysozyme D61H/K65H by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–162(162 aa)
Chain B
1–162(162 aa)
|
Mutation:C54T, D61H, K65H, C97A
Mutation:C54T, D61H, K65H, C97A
|
CU COPPER (II) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;290 K;3.5M Sodium Formate, pH 7.0, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.65 Å
R-free 0.273
|
|
3SB8
Cu-mediated Dimer of T4 Lysozyme D61H/K65H by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–162(162 aa)
|
Mutation:C54T, D61H, K65H, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;290 K;3.5M Sodium Formate, pH 7.0, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.65 Å
R-free 0.273
|
|
3SB9
Cu-mediated Dimer of T4 Lysozyme R76H/R80H by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–162(162 aa)
Chain B
1–162(162 aa)
|
Mutation:C54T, R76H, R80H, C97A
Mutation:C54T, R76H, R80H, C97A
|
FMT FORMIC ACID × 2
CU COPPER (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;290 K;3.5M Sodium Formate, pH 7.0, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.45 Å
R-free 0.239
|
|
3SBA
Zn-mediated Hexamer of T4 Lysozyme R76H/R80H by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–162(162 aa)
Chain B
1–162(162 aa)
Chain C
1–162(162 aa)
Chain D
1–162(162 aa)
Chain E
1–162(162 aa)
Chain F
1–162(162 aa)
|
Mutation:C54T, R76H, R80H, C97A
Mutation:C54T, R76H, R80H, C97A
Mutation:C54T, R76H, R80H, C97A
Mutation:C54T, R76H, R80H, C97A
Mutation:C54T, R76H, R80H, C97A
Mutation:C54T, R76H, R80H, C97A
|
ZN ZINC ION × 3
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;290 K;0.17M Ammonium Acetate, 0.085 Sodium Acetate Trihydrate, 25.5% PEG 4000, 15% Glycerol, pH 4.6, vapor diffusion, hanging drop, temperature 290K
|
Resolution 2.75 Å
R-free 0.278
|
|
3SBB
Disulphide-mediated Tetramer of T4 Lysozyme R76C/R80C by Synthetic Symmetrization
Deposited 2011-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–162(162 aa)
|
Mutation:C54T, R76C, R80C, C97A
|
CL CHLORIDE ION × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;290 K;4.3M Sodium Chloride, 0.1M HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 290K
|
Resolution 1.43 Å
R-free 0.177
|
|
3SN6
Crystal structure of the beta2 adrenergic receptor-Gs protein complex
Deposited 2011-06-28
|
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
2–161(160 aa)
|
Mutation:C54T,C97A,M96T,M98T,N187E
|
P0G 8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.5;293 K;350-450 mM potassium nitrate, 100 mM MES, 1 mM TCEP, 10 mM phosphonoformate, 0.01 mM BI167107, 18-22% PEG400. Crystals were grown in a 10:1 (w:w) MAG 7.7:cholesterol lipid mix. , pH 6.5, Lipidic cubic phase, temperature 293K
|
Resolution 3.20 Å
R-free 0.277
|
|
3UON
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Deposited 2011-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:UNP RESIDUES 1-217, UNP RESIDUES 2-161, UNP RESIDUES 377-466
|
Mutation:N2D, N3D, N6D, N9D, C54T, C97A
|
QNB (3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate × 1
BGC beta-D-glucopyranose × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;25 to 35% PEG 300, 100 mM ammonium phosphate, 2% 2-Methyl-2,4-pentanediol, 100 mM HEPES, 10:1 monoolein:cholesterol lipid mix diluted 1.5:1 with protein in detergent buffer, Lipidic cubic phase, temperature 293K, pH 7.5
|
Resolution 3.00 Å
R-free 0.276
|
|
3V2W
Crystal Structure of a Lipid G protein-Coupled Receptor at 3.35A
Deposited 2011-12-12
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:C1054T, C1097A
|
ML5 {(3R)-3-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl}phosphonic acid × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
Lupuc cubic phase;287 K;0.1M Tricine, 34-36% PEG400, 80mM sodium citrate and 4% glycerol, Lupuc cubic phase, temperature 287K
|
Resolution 3.35 Å
R-free 0.281
|
|
3V2Y
Crystal Structure of a Lipid G protein-Coupled Receptor at 2.80A
Deposited 2011-12-12
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:C1054T, C1097A
|
ML5 {(3R)-3-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl}phosphonic acid × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
Lipid cubic phase;287 K;0.1M Tricine, 34-36% PEG400, 80mM sodium citrate and 4% glycerol, Lipid cubic phase, temperature 287K
|
Resolution 2.80 Å
R-free 0.272
|
|
3VW7
Crystal structure of human protease-activated receptor 1 (PAR1) bound with antagonist vorapaxar at 2.2 angstrom
Deposited 2012-08-07
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:N250G, N259S, D1020N, C1054T, C1097A
|
VPX ethyl [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl}-1-methyl-3-oxododecahydronaphtho[2,3-c]fur an-6-yl]carbamate × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 9
CL CHLORIDE ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
293 K;0.1-0.2M sodium chloride, 100mM sodium phosphate pH 6.0-6.5, 25%-35% PEG 300, Lipidic cubic phase (in meso phase), temperature 293K
|
Resolution 2.20 Å
R-free 0.235
|
|
4ARJ
Crystal structure of a pesticin (translocation and receptor binding domain) from Y. pestis and T4-lysozyme chimera
Deposited 2012-04-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–164(163 aa)
Fragment:N-TERMINAL DOMAIN OF PESTICIN, RESIDUES 1-167
|
Mutation:YES
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;20% PEG 3350 0.15 M K2(SO4), pH 7
|
Resolution 2.59 Å
R-free 0.237
|
|
4ARJ
Crystal structure of a pesticin (translocation and receptor binding domain) from Y. pestis and T4-lysozyme chimera
Deposited 2012-04-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–164(163 aa)
Fragment:N-TERMINAL DOMAIN OF PESTICIN, RESIDUES 1-167
|
Mutation:YES
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;20% PEG 3350 0.15 M K2(SO4), pH 7
|
Resolution 2.59 Å
R-free 0.237
|
|
4DAJ
Structure of the M3 Muscarinic Acetylcholine Receptor
Deposited 2012-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
|
Mutation:C1054T, C1097A
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
PO4 PHOSPHATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;27-38% PEG 300, 100 mM HEPES pH 7.5, 1% (w/w) 1,2,3-heptanetriol, and 100 mM ammonium phosphate. Protein was reconstituted in cubic phase using a 10:1 monolein:cholesterol mix by weight, Lipidic cubic phase, temperature 293K
|
Resolution 3.40 Å
R-free 0.303
|
|
4DAJ
Structure of the M3 Muscarinic Acetylcholine Receptor
Deposited 2012-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
|
Mutation:C1054T, C1097A
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;27-38% PEG 300, 100 mM HEPES pH 7.5, 1% (w/w) 1,2,3-heptanetriol, and 100 mM ammonium phosphate. Protein was reconstituted in cubic phase using a 10:1 monolein:cholesterol mix by weight, Lipidic cubic phase, temperature 293K
|
Resolution 3.40 Å
R-free 0.303
|
|
4DAJ
Structure of the M3 Muscarinic Acetylcholine Receptor
Deposited 2012-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
|
Mutation:C1054T, C1097A
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;27-38% PEG 300, 100 mM HEPES pH 7.5, 1% (w/w) 1,2,3-heptanetriol, and 100 mM ammonium phosphate. Protein was reconstituted in cubic phase using a 10:1 monolein:cholesterol mix by weight, Lipidic cubic phase, temperature 293K
|
Resolution 3.40 Å
R-free 0.303
|
|
4DAJ
Structure of the M3 Muscarinic Acetylcholine Receptor
Deposited 2012-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
|
Mutation:C1054T, C1097A
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
PO4 PHOSPHATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;27-38% PEG 300, 100 mM HEPES pH 7.5, 1% (w/w) 1,2,3-heptanetriol, and 100 mM ammonium phosphate. Protein was reconstituted in cubic phase using a 10:1 monolein:cholesterol mix by weight, Lipidic cubic phase, temperature 293K
|
Resolution 3.40 Å
R-free 0.303
|
|
4DAJ
Structure of the M3 Muscarinic Acetylcholine Receptor
Deposited 2012-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
Chain B
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
|
Mutation:C1054T, C1097A
Mutation:C1054T, C1097A
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 2
PO4 PHOSPHATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;27-38% PEG 300, 100 mM HEPES pH 7.5, 1% (w/w) 1,2,3-heptanetriol, and 100 mM ammonium phosphate. Protein was reconstituted in cubic phase using a 10:1 monolein:cholesterol mix by weight, Lipidic cubic phase, temperature 293K
|
Resolution 3.40 Å
R-free 0.303
|
|
4DAJ
Structure of the M3 Muscarinic Acetylcholine Receptor
Deposited 2012-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
Chain D
1–161(161 aa)
Fragment:P08483 residues 57-259, 482-589, P00720 residues 1-161
|
Mutation:C1054T, C1097A
Mutation:C1054T, C1097A
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 2
PO4 PHOSPHATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;27-38% PEG 300, 100 mM HEPES pH 7.5, 1% (w/w) 1,2,3-heptanetriol, and 100 mM ammonium phosphate. Protein was reconstituted in cubic phase using a 10:1 monolein:cholesterol mix by weight, Lipidic cubic phase, temperature 293K
|
Resolution 3.40 Å
R-free 0.303
|
|
4DJH
Structure of the human kappa opioid receptor in complex with JDTic
Deposited 2012-02-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP P41145 residues 43-261, UNP P00720 residues 2-161, UNP P41145 residues 362-358
Chain B
2–161(160 aa)
Fragment:UNP P41145 residues 43-261, UNP P00720 residues 2-161, UNP P41145 residues 362-358
|
Mutation:I135L, C54T, C97A
Mutation:I135L, C54T, C97A
|
JDC (3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl}-1,2,3,4-tetrahydroisoquinoline-3-carboxamide × 2
CIT CITRIC ACID × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;100 mM sodium citrate pH 6.0, 30% (v/v) PEG400, 400 mM potassium nitrate, lipidic cubic phase, temperature 293K
|
Resolution 2.90 Å
R-free 0.265
|
|
4DJH
Structure of the human kappa opioid receptor in complex with JDTic
Deposited 2012-02-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP P41145 residues 43-261, UNP P00720 residues 2-161, UNP P41145 residues 362-358
Chain B
2–161(160 aa)
Fragment:UNP P41145 residues 43-261, UNP P00720 residues 2-161, UNP P41145 residues 362-358
|
Mutation:I135L, C54T, C97A
Mutation:I135L, C54T, C97A
|
JDC (3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl}-1,2,3,4-tetrahydroisoquinoline-3-carboxamide × 2
CIT CITRIC ACID × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;100 mM sodium citrate pH 6.0, 30% (v/v) PEG400, 400 mM potassium nitrate, lipidic cubic phase, temperature 293K
|
Resolution 2.90 Å
R-free 0.265
|
|
4DKL
Crystal structure of the mu-opioid receptor bound to a morphinan antagonist
Deposited 2012-02-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:SEE REMARK 999
|
Mutation:D1020N, C1054T, C1097A
|
BF0 methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate × 2
SO4 SULFATE ION × 24
CLR CHOLESTEROL × 2
MPG [(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate × 4
1PE PENTAETHYLENE GLYCOL × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7;293 K;100 mM HEPES, pH 7.0, 300 mM lithium sulfate, 7.5% DMSO, 30-38% PEG400 in monoolein:cholesterol mixed in a 10:1 ratio, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 2.80 Å
R-free 0.275
|
|
4E97
T4 Lysozyme L99A/M102H with 2-Mercaptoethanol Bound
Deposited 2012-03-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 5
SO4 SULFATE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.30 Å
R-free 0.166
|
|
4E97
T4 Lysozyme L99A/M102H with 2-Mercaptoethanol Bound
Deposited 2012-03-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
SO4 SULFATE ION × 2
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.30 Å
R-free 0.166
|
|
4EJ4
Structure of the delta opioid receptor bound to naltrindole
Deposited 2012-04-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:P32300 residues 36-244, 251-342
|
Mutation:D1020N, C1054T, C1097A
|
EJ4 (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-4,8-methano[1]benzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;29-33% PEG 400, 100 mM HEPES pH 7.5, 120-180 mM sodium citrate, 350 mM Magnesium chloride. Protein was mixed 1:1.5 (w:w) with 91% monoolein 9% cholesterol mixture by weight, Lipidic cubic phase, temperature 293K
|
Resolution 3.40 Å
R-free 0.282
|
|
4EKP
T4 Lysozyme L99A/M102H with Nitrobenzene Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 2
NBZ NITROBENZENE × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.64 Å
R-free 0.196
|
|
4EKP
T4 Lysozyme L99A/M102H with Nitrobenzene Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 2
NBZ NITROBENZENE × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.64 Å
R-free 0.196
|
|
4EKP
T4 Lysozyme L99A/M102H with Nitrobenzene Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 4
NBZ NITROBENZENE × 2
SO4 SULFATE ION × 5
ACT ACETATE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.64 Å
R-free 0.196
|
|
4EKQ
T4 Lysozyme L99A/M102H with 4-Nitrophenol Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 1
NPO P-NITROPHENOL × 2
SO4 SULFATE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.54 Å
R-free 0.204
|
|
4EKQ
T4 Lysozyme L99A/M102H with 4-Nitrophenol Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 1
NPO P-NITROPHENOL × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.54 Å
R-free 0.204
|
|
4EKR
T4 Lysozyme L99A/M102H with 2-Cyanophenol Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 2
0R0 2-hydroxybenzonitrile × 2
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.49 Å
R-free 0.206
|
|
4EKR
T4 Lysozyme L99A/M102H with 2-Cyanophenol Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 1
0R0 2-hydroxybenzonitrile × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.49 Å
R-free 0.206
|
|
4EKR
T4 Lysozyme L99A/M102H with 2-Cyanophenol Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 3
0R0 2-hydroxybenzonitrile × 3
SO4 SULFATE ION × 4
ACT ACETATE ION × 4
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.49 Å
R-free 0.206
|
|
4EKS
T4 Lysozyme L99A/M102H with Isoxazole Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 2
0R1 1,2-benzisoxazole × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.64 Å
R-free 0.198
|
|
4EKS
T4 Lysozyme L99A/M102H with Isoxazole Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 2
0R1 1,2-benzisoxazole × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.64 Å
R-free 0.198
|
|
4EKS
T4 Lysozyme L99A/M102H with Isoxazole Bound
Deposited 2012-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
Chain B
1–164(164 aa)
|
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
Mutation:T21C/S38D/L99A/M102H/E108V/S117V/T142C/N144D
|
BME BETA-MERCAPTOETHANOL × 4
0R1 1,2-benzisoxazole × 2
SO4 SULFATE ION × 5
ACT ACETATE ION × 3
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.64 Å
R-free 0.198
|
|
4EPI
The crystal structure of pesticin-T4 lysozyme hybrid stabilized by engineered disulfide bonds
Deposited 2012-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
4–165(162 aa)
Fragment:SEE REMARK 999
|
Mutation:I168C,I174C,C219T,L329C
|
SO4 SULFATE ION × 2
NA SODIUM ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;20% w/v PEG3350, 0.25 M calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.74 Å
R-free 0.200
|
|
4EXM
The crystal structure of an engineered phage lysin containing the binding domain of pesticin and the killing domain of T4-lysozyme
Deposited 2012-04-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
4–165(162 aa)
Fragment:SEE REMARK 999
Chain D
4–165(162 aa)
Fragment:SEE REMARK 999
|
Mutation:G182R,C267T,C267A,R307I
Mutation:G182R,C267T,C267A,R307I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;20% w/v PEG3350, 0.25 M calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.60 Å
R-free 0.251
|
|
4EXM
The crystal structure of an engineered phage lysin containing the binding domain of pesticin and the killing domain of T4-lysozyme
Deposited 2012-04-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
4–165(162 aa)
Fragment:SEE REMARK 999
Chain C
4–165(162 aa)
Fragment:SEE REMARK 999
|
Mutation:G182R,C267T,C267A,R307I
Mutation:G182R,C267T,C267A,R307I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;20% w/v PEG3350, 0.25 M calcium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.60 Å
R-free 0.251
|
|
4GBR
N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor
Deposited 2012-07-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–161(160 aa)
Fragment:UNP RESIDUES 2-161
|
Not recorded
|
CAU (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;293 K;PEG300 37%
Bis-Tris propane 0.1M
Ammonium phosphate, dibasic, 0.1M, pH 6.5, lipidic cubic phase, temperature 293K
|
Resolution 3.99 Å
R-free 0.282
|
|
4GRV
The crystal structure of the neurotensin receptor NTS1 in complex with neurotensin (8-13)
Deposited 2012-08-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:see remark 999
|
Mutation:A86L, E166A, G215A, L310A, F358A, V360A
|
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
Lipid cubic phase (LCP);pH 7.4;298 K;80 mM HEPES pH 7.0, 2 mM TCEP, 43 mM NaK tartrate, 20.8% PEG400, Lipid cubic phase (LCP), temperature 298K
|
Resolution 2.80 Å
R-free 0.282
|
|
4HTT
Crystal Structure of Twin Arginine Translocase Receptor- TatC in DDM
Deposited 2012-11-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;35% (v/v) PEG 400, ADA pH 6.6 and 0.1 M Potassium phosphate monobasic., VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 6.80 Å
R-free 0.418
|
|
4HTT
Crystal Structure of Twin Arginine Translocase Receptor- TatC in DDM
Deposited 2012-11-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;35% (v/v) PEG 400, ADA pH 6.6 and 0.1 M Potassium phosphate monobasic., VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 6.80 Å
R-free 0.418
|
|
4I7J
T4 Lysozyme L99A/M102H with benzene bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 4
BNZ BENZENE × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.67 Å
R-free 0.239
|
|
4I7J
T4 Lysozyme L99A/M102H with benzene bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
BNZ BENZENE × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.67 Å
R-free 0.239
|
|
4I7K
T4 Lysozyme L99A/M102H with toluene bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
MBN TOLUENE × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.72 Å
R-free 0.201
|
|
4I7K
T4 Lysozyme L99A/M102H with toluene bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 4
MBN TOLUENE × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.72 Å
R-free 0.201
|
|
4I7L
T4 Lysozyme L99A/M102H with phenol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
IPH PHENOL × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.52 Å
R-free 0.181
|
|
4I7L
T4 Lysozyme L99A/M102H with phenol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
IPH PHENOL × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.52 Å
R-free 0.181
|
|
4I7M
T4 Lysozyme L99A/M102H with 2-allylphenol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
2LP 2-ALLYLPHENOL × 1
SO4 SULFATE ION × 2
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.48 Å
R-free 0.198
|
|
4I7M
T4 Lysozyme L99A/M102H with 2-allylphenol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
2LP 2-ALLYLPHENOL × 1
SO4 SULFATE ION × 4
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.48 Å
R-free 0.198
|
|
4I7N
T4 Lysozyme L99A/M102H with 1-phenyl-2-propyn-1-ol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
1DJ (1R)-1-phenylprop-2-yn-1-ol × 1
SO4 SULFATE ION × 4
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.58 Å
R-free 0.202
|
|
4I7N
T4 Lysozyme L99A/M102H with 1-phenyl-2-propyn-1-ol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
1DJ (1R)-1-phenylprop-2-yn-1-ol × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.58 Å
R-free 0.202
|
|
4I7O
T4 Lysozyme L99A/M102H with 2-amino-5-chlorothiazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
1DH 5-chloro-1,3-thiazol-2-amine × 1
SO4 SULFATE ION × 5
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.73 Å
R-free 0.194
|
|
4I7O
T4 Lysozyme L99A/M102H with 2-amino-5-chlorothiazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
1DH 5-chloro-1,3-thiazol-2-amine × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.73 Å
R-free 0.194
|
|
4I7P
T4 Lysozyme L99A/M102H with 4-bromoimidazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
ES3 4-bromo-1H-imidazole × 1
SO4 SULFATE ION × 6
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.60 Å
R-free 0.204
|
|
4I7P
T4 Lysozyme L99A/M102H with 4-bromoimidazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 1
ES3 4-bromo-1H-imidazole × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.60 Å
R-free 0.204
|
|
4I7Q
T4 Lysozyme L99A/M102H with 4-trifluoromethylimidazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
1DQ 5-(trifluoromethyl)-1H-imidazole × 1
SO4 SULFATE ION × 6
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.58 Å
R-free 0.213
|
|
4I7Q
T4 Lysozyme L99A/M102H with 4-trifluoromethylimidazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
1DQ 5-(trifluoromethyl)-1H-imidazole × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.58 Å
R-free 0.213
|
|
4I7R
T4 Lysozyme L99A/M102H with 2-(pyrazolo-1-yl) ethanol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
1DU 2-(1H-pyrazol-1-yl)ethanol × 1
SO4 SULFATE ION × 4
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.52 Å
R-free 0.190
|
|
4I7R
T4 Lysozyme L99A/M102H with 2-(pyrazolo-1-yl) ethanol bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 3
1DU 2-(1H-pyrazol-1-yl)ethanol × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.52 Å
R-free 0.190
|
|
4I7S
T4 Lysozyme L99A/M102H with 3-trifluoromethyl-5-methyl pyrazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 1
1DV 5-methyl-3-(trifluoromethyl)-1H-pyrazole × 1
SO4 SULFATE ION × 4
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.69 Å
R-free 0.196
|
|
4I7S
T4 Lysozyme L99A/M102H with 3-trifluoromethyl-5-methyl pyrazole bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 1
1DV 5-methyl-3-(trifluoromethyl)-1H-pyrazole × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.69 Å
R-free 0.196
|
|
4I7T
T4 Lysozyme L99A/M102H with 2-bromo-5-hydroxybenzaldehyde bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
1DW 2-bromo-5-hydroxybenzaldehyde × 1
SO4 SULFATE ION × 3
ACT ACETATE ION × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.55 Å
R-free 0.199
|
|
4I7T
T4 Lysozyme L99A/M102H with 2-bromo-5-hydroxybenzaldehyde bound
Deposited 2012-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Mutation:T21C, S38D, L99A, M102H, E108V, S117V, T142C, N144D
|
BME BETA-MERCAPTOETHANOL × 2
1DW 2-bromo-5-hydroxybenzaldehyde × 1
SO4 SULFATE ION × 2
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3% (w/v) TMAO, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.55 Å
R-free 0.199
|
|
4IAP
Crystal structure of PH domain of Osh3 from Saccharomyces cerevisiae
Deposited 2012-12-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:PH domain (UNP residues 221-317), T4 Lysozyme (UNP residues 2-161),PH domain (UNP residues 237-315)
|
Mutation:D1020N, C1054T, C1097A
|
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;295 K;0.1M Tris-HCl, 15% PEG8000, 0.2 M
Li2SO4, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 2.30 Å
R-free 0.274
|
|
4IAP
Crystal structure of PH domain of Osh3 from Saccharomyces cerevisiae
Deposited 2012-12-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
Fragment:PH domain (UNP residues 221-317), T4 Lysozyme (UNP residues 2-161),PH domain (UNP residues 237-315)
|
Mutation:D1020N, C1054T, C1097A
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;295 K;0.1M Tris-HCl, 15% PEG8000, 0.2 M
Li2SO4, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 2.30 Å
R-free 0.274
|
|
4IAP
Crystal structure of PH domain of Osh3 from Saccharomyces cerevisiae
Deposited 2012-12-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:PH domain (UNP residues 221-317), T4 Lysozyme (UNP residues 2-161),PH domain (UNP residues 237-315)
Chain B
2–161(160 aa)
Fragment:PH domain (UNP residues 221-317), T4 Lysozyme (UNP residues 2-161),PH domain (UNP residues 237-315)
|
Mutation:D1020N, C1054T, C1097A
Mutation:D1020N, C1054T, C1097A
|
SO4 SULFATE ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;295 K;0.1M Tris-HCl, 15% PEG8000, 0.2 M
Li2SO4, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 2.30 Å
R-free 0.274
|
|
4K5Y
Crystal structure of human corticotropin-releasing factor receptor 1 (CRF1R) in complex with the antagonist CP-376395
Deposited 2013-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:UNP P34998 RESIDUES 104-220, UNP P00720 RESIDUES 2-161, UNP P34998 RESIDUES 224-373
|
Mutation:v120a, l144a, w156a, s160a, n40s, a41v, c54s, c97s, t151a, k228a, f260a, i277a, y309a, f330a, s349a, y363a
|
1Q5 3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine × 1
OLA OLEIC ACID × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5.5;295.6 K;30% (v/v) PEG 400, 0.2M lithium sulphate, 0.1M sodium citrate 5.5, Lipidic Cubic Phase, temperature 295.6K
|
Resolution 2.98 Å
R-free 0.265
|
|
4K5Y
Crystal structure of human corticotropin-releasing factor receptor 1 (CRF1R) in complex with the antagonist CP-376395
Deposited 2013-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
Fragment:UNP P34998 RESIDUES 104-220, UNP P00720 RESIDUES 2-161, UNP P34998 RESIDUES 224-373
|
Mutation:v120a, l144a, w156a, s160a, n40s, a41v, c54s, c97s, t151a, k228a, f260a, i277a, y309a, f330a, s349a, y363a
|
1Q5 3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
SO4 SULFATE ION × 3
PGW (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate × 3
1PE PENTAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5.5;295.6 K;30% (v/v) PEG 400, 0.2M lithium sulphate, 0.1M sodium citrate 5.5, Lipidic Cubic Phase, temperature 295.6K
|
Resolution 2.98 Å
R-free 0.265
|
|
4K5Y
Crystal structure of human corticotropin-releasing factor receptor 1 (CRF1R) in complex with the antagonist CP-376395
Deposited 2013-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
2–161(160 aa)
Fragment:UNP P34998 RESIDUES 104-220, UNP P00720 RESIDUES 2-161, UNP P34998 RESIDUES 224-373
|
Mutation:v120a, l144a, w156a, s160a, n40s, a41v, c54s, c97s, t151a, k228a, f260a, i277a, y309a, f330a, s349a, y363a
|
1Q5 3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine × 1
OLA OLEIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5.5;295.6 K;30% (v/v) PEG 400, 0.2M lithium sulphate, 0.1M sodium citrate 5.5, Lipidic Cubic Phase, temperature 295.6K
|
Resolution 2.98 Å
R-free 0.265
|
|
4LDE
Structure of beta2 adrenoceptor bound to BI167107 and an engineered nanobody
Deposited 2013-06-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP residues 29-348 with a deletion of residues 235-263
|
Mutation:C918T, C962A, M1096T, M1098T, N1157E, C1265A
|
P0G 8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one × 1
NA SODIUM ION × 1
1WV (2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.5;293 K;100 mM MES pH 6.2-6.7, 40-100 mM ammonium phosphate dibasic, 18-24% PEG400, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 2.79 Å
R-free 0.256
|
|
4LDL
Structure of beta2 adrenoceptor bound to hydroxybenzylisoproterenol and an engineered nanobody
Deposited 2013-06-24
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
|
Mutation:C918T, C962A, M1096T, M1098T, N1157E, C1265A
|
XQC 4-[(1R)-1-hydroxy-2-{[1-(4-hydroxyphenyl)-2-methylpropan-2-yl]amino}ethyl]benzene-1,2-diol × 1
NA SODIUM ION × 1
1WV (2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.5;293 K;100 mM MES pH 6.2-6.7, 40-100 mM ammonium phosphate dibasic, 18-24% PEG400, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 3.10 Å
R-free 0.254
|
|
4LDO
Structure of beta2 adrenoceptor bound to adrenaline and an engineered nanobody
Deposited 2013-06-24
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
|
Mutation:C918T, C962A, M1096T, M1098T, N1157E, C1265A
|
1WV (2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate × 1
ALE L-EPINEPHRINE × 1
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.5;293 K;100 mM MES pH 6.2-6.7, 40-100 mM ammonium phosphate dibasic, 18-24% PEG400, LIPIDIC CUBIC PHASE, temperature 293K
|
Resolution 3.20 Å
R-free 0.254
|
|
4LZM
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STRENGTHS
Deposited 1991-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
|
|
4N9N
Crystal Structure of Saccharomyces cerevisiae Upc2 Transcription Factor fused with T4 Lysozyme
Deposited 2013-10-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:residues 598-714 and 726-878 of Q12151, residues 2-161 of P00720
Chain B
2–161(160 aa)
Fragment:residues 598-714 and 726-878 of Q12151, residues 2-161 of P00720
|
Mutation:C1054T, C1097A
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:C1054T, C1097A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;0.1M HEPES, 12.5% PEG 8000, 0.2M sodium citrate, 7.5% glycerol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 2.90 Å
R-free 0.272
|
|
4OO9
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator mavoglurant
Deposited 2014-01-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–162(161 aa)
Fragment:SEE REMARK 999
|
Mutation:yes
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
OLA OLEIC ACID × 4
2U8 Mavoglurant × 1
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.8;293.1 K;24-34% v/v PEG400, 0.2 M ammonium phosphate dibasic, 0.1 M MES, pH 6.8, LIPIDIC CUBIC PHASE, temperature 293.1K
|
Resolution 2.60 Å
R-free 0.275
|
|
4PHU
Crystal structure of Human GPR40 bound to allosteric agonist TAK-875
Deposited 2014-05-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:UNP O14842 residues 2-213, UNP P00720 residues 2-161, UNP O14842 residues 214-300
|
Mutation:L42A,F88A,G103A,Y202F,S211G,G212S,C1154T,C1197A
|
2YB [(3S)-6-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy]biphenyl-3-yl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 5
1PE PENTAETHYLENE GLYCOL × 1
DMS DIMETHYL SULFOXIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 8;294 K;29-31% Peg 400,100 mM Tris pH 8.0. 0.2 M Na Malonate,200 uM TAK-875
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.2;294 K;39.8 % Peg 400, 100 mM Bis-Tris-Propane pH 7.2, 0.1 Ammonium Phosphate (monobasic), 200 uM TAK-875
|
Resolution 2.33 Å
R-free 0.233
|
|
4RWS
Crystal structure of CXCR4 and viral chemokine antagonist vMIP-II complex (PSI Community Target)
Deposited 2014-12-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1002–1161(160 aa)
Fragment:CXCR4 residues 2-228, LYSOZYME residues 1002-1161, CXCR4 residues 231-319
|
Mutation:L125W, T240P, D187C, C1054T, C1097T
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5.5;293 K;100 mM sodium citrate pH 5.5, 28% PEG 400, 120 mM ammonium phosphate dibasic, 2-6% polypropylene P400, Lipidic cubic phase, temperature 293K
|
Resolution 3.10 Å
R-free 0.274
|
|
4TN3
Structure of the BBox-Coiled-coil region of Rhesus Trim5alpha
Deposited 2014-06-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
Chain B
1–164(164 aa)
|
Not recorded
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;10% PEG4000, 20% Glycerol, 0.2M monosaccharides, 0.1M Bis/Tris pH 8.5
|
Resolution 3.20 Å
R-free 0.316
|
|
4U14
Structure of the M3 muscarinic acetylcholine receptor bound to the antagonist tiotropium crystallized with disulfide-stabilized T4 lysozyme (dsT4L)
Deposited 2014-07-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–161(161 aa)
Fragment:UNP P08483 residues 57-259, 482-563, P00720 residues 1-161
|
Not recorded
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 8.1;298 K;45% PEG 300, 110 mM ammonium sulfate, 113.5 mM lithium citrate, 100 mM Tris
|
Resolution 3.57 Å
R-free 0.325
|
|
4U14
Structure of the M3 muscarinic acetylcholine receptor bound to the antagonist tiotropium crystallized with disulfide-stabilized T4 lysozyme (dsT4L)
Deposited 2014-07-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–161(161 aa)
Fragment:UNP P08483 residues 57-259, 482-563, P00720 residues 1-161
|
Not recorded
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 8.1;298 K;45% PEG 300, 110 mM ammonium sulfate, 113.5 mM lithium citrate, 100 mM Tris
|
Resolution 3.57 Å
R-free 0.325
|
|
4W51
T4 Lysozyme L99A with No Ligand Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.45 Å
R-free 0.192
|
|
4W52
T4 Lysozyme L99A with Benzene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
BNZ BENZENE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.50 Å
R-free 0.182
|
|
4W53
T4 Lysozyme L99A with Toluene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
MBN TOLUENE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.56 Å
R-free 0.205
|
|
4W54
T4 Lysozyme L99A with Ethylbenzene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
PYJ PHENYLETHANE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.79 Å
R-free 0.198
|
|
4W55
T4 Lysozyme L99A with n-Propylbenzene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
3H0 propylbenzene × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.64 Å
R-free 0.187
|
|
4W56
T4 Lysozyme L99A with sec-Butylbenzene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
3GY (2R)-butan-2-ylbenzene × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.63 Å
R-free 0.188
|
|
4W57
T4 Lysozyme L99A with n-Butylbenzene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
N4B N-BUTYLBENZENE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.68 Å
R-free 0.185
|
|
4W58
T4 Lysozyme L99A with n-Pentylbenzene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
3H2 pentylbenzene × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.80 Å
R-free 0.184
|
|
4W59
T4 Lysozyme L99A with n-Hexylbenzene Bound
Deposited 2014-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:L99A
|
3GZ hexylbenzene × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% (w/v) PEGF-4000, 10% 2-propanol, 0.1 M HEPES, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.39 Å
R-free 0.187
|
|
4W8F
Crystal structure of the dynein motor domain in the AMPPNP-bound state
Deposited 2014-08-24
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:E1849Q
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 4
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;4-10% PEG 3350 and 200-300 mM NaAc
|
Resolution 3.54 Å
R-free 0.262
|
|
4W8F
Crystal structure of the dynein motor domain in the AMPPNP-bound state
Deposited 2014-08-24
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Mutation:E1849Q
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 4
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;4-10% PEG 3350 and 200-300 mM NaAc
|
Resolution 3.54 Å
R-free 0.262
|
|
4W8F
Crystal structure of the dynein motor domain in the AMPPNP-bound state
Deposited 2014-08-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Chain B
2–161(160 aa)
|
Mutation:E1849Q
Mutation:E1849Q
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 8
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;4-10% PEG 3350 and 200-300 mM NaAc
|
Resolution 3.54 Å
R-free 0.262
|
|
4WTV
Crystal structure of the phosphatidylinositol 4-kinase IIbeta
Deposited 2014-10-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–164(163 aa)
Fragment:;UNP residues 90-165,UNP residues 2-164,UNP residues 176-450,UNP residues 90-165,UNP residues 2-164,UNP residues 176-450,UNP residues 90-165,UNP residues 2-164,UNP residues 176-450
;
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;100 mM MES/Imidazole pH = 6.5, 10% w/v PEG 4000, 20% v/v glycerol, 20 mM 1,6-hexanediol, 20 mM 1-butanol, 20 mM 1,2-propanediol, 20 mM 2-propanol, 20 mM 1,4-butanediol, 20 mM 1,3-propanediol
|
Resolution 1.90 Å
R-free 0.240
|
|
4WTV
Crystal structure of the phosphatidylinositol 4-kinase IIbeta
Deposited 2014-10-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–164(163 aa)
Fragment:;UNP residues 90-165,UNP residues 2-164,UNP residues 176-450,UNP residues 90-165,UNP residues 2-164,UNP residues 176-450,UNP residues 90-165,UNP residues 2-164,UNP residues 176-450
;
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;100 mM MES/Imidazole pH = 6.5, 10% w/v PEG 4000, 20% v/v glycerol, 20 mM 1,6-hexanediol, 20 mM 1-butanol, 20 mM 1,2-propanediol, 20 mM 2-propanol, 20 mM 1,4-butanediol, 20 mM 1,3-propanediol
|
Resolution 1.90 Å
R-free 0.240
|
|
4XEE
Structure of active-like neurotensin receptor
Deposited 2014-12-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP residues 43-396 (P20789), residues 2-161 (P00720)
|
Mutation:A86L, G215A, V360A
|
1PE PENTAETHYLENE GLYCOL × 2
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
FLC CITRATE ANION × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;16-24% PEG400, 75 mM HEPES, pH 7.0-8.0, 1.7 mM TCEP, 32 mM lithium citrate, 0.9 mM Neurotensin (8-13)
|
Resolution 2.90 Å
R-free 0.281
|
|
4XES
Structure of active-like neurotensin receptor
Deposited 2014-12-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP residues 43-396 (P20789), residues 2-161 (P00720)
|
Mutation:A86L, E166A, G215A, V360A
|
CIT CITRIC ACID × 1
PEG DI(HYDROXYETHYL)ETHER × 5
GOL GLYCEROL × 3
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;19.8-23.4% PEG400, 80 mM HEPES, 50 mM lithium citrate, 2 mM TCEP
|
Resolution 2.60 Å
R-free 0.280
|
|
4YX7
Complex of SpaO(SPOA1,2) and OrgB(APAR)::T4lysozyme fusion protein
Deposited 2015-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2–164(163 aa)
Fragment:UNP Residues 1-30,UNP Residues 1-30
|
Mutation:D20N,C54T,C97A,D20N,C54T,C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;SpaO(145-213) + SpaO (232-297) + OrgB(1-30)::T4 lysozyme was concentrated to 18.5mg/mL and crystallized with 25% PEG3350, 200mM ammonium formate, 100mM sodium acetate pH=5.0. Microseeding was employed to enhance crystal uniformity and diffraction. Briefly, crystals to be seeded were harvested in precipitant solution and vortexed in a microfuge tube with a small stir bar for ~60 seconds. The slurry of microseeds was serially dilluted (5-10-fold steps) in precipitant solution and 5 selected microseed-precipitant mixtures were mixed with fresh protein as in a normal hanging drop experiment. Crystals were cryoprotected in 30% PEG3350, 10% glycerol, 200mM ammonium acetate, 100mM sodium acetate pH=5.0.
|
Resolution 2.00 Å
R-free 0.210
|
|
4YX7
Complex of SpaO(SPOA1,2) and OrgB(APAR)::T4lysozyme fusion protein
Deposited 2015-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
2–164(163 aa)
Fragment:UNP Residues 1-30,UNP Residues 1-30
|
Mutation:D20N,C54T,C97A,D20N,C54T,C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;SpaO(145-213) + SpaO (232-297) + OrgB(1-30)::T4 lysozyme was concentrated to 18.5mg/mL and crystallized with 25% PEG3350, 200mM ammonium formate, 100mM sodium acetate pH=5.0. Microseeding was employed to enhance crystal uniformity and diffraction. Briefly, crystals to be seeded were harvested in precipitant solution and vortexed in a microfuge tube with a small stir bar for ~60 seconds. The slurry of microseeds was serially dilluted (5-10-fold steps) in precipitant solution and 5 selected microseed-precipitant mixtures were mixed with fresh protein as in a normal hanging drop experiment. Crystals were cryoprotected in 30% PEG3350, 10% glycerol, 200mM ammonium acetate, 100mM sodium acetate pH=5.0.
|
Resolution 2.00 Å
R-free 0.210
|
|
4YXA
Complex of SpaO(SPOA1,2 SeMet) and OrgB(APAR)::T4lysozyme fusion protein
Deposited 2015-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2–164(163 aa)
Fragment:UNP Residues 1-30,UNP Residues 1-30
|
Mutation:D20N, C54T, C97A,D20N, C54T, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;SpaO(145-213, SeMet) + SpaO (232-297, SeMet) + OrgB(1-30)::T4 lysozyme (native) was concentrated to 18mg/mL, supplemented with 50mM maltose, and crystallized with 25% PEG3350, 200mM ammonium formate, 100mM sodium acetate pH=5.0. Microseeding was employed to enhance crystal uniformity and diffraction. Briefly, crystals to be seeded were harvested in precipitant solution and vortexed in a microfuge tube with a small stir bar for ~60 seconds. The slurry of microseeds was serially dilluted (5-10-fold steps) in precipitant solution and 5 selected microseed-precipitant mixtures were mixed with fresh protein as in a normal hanging drop experiment. Crystals were cryoprotected in 25% PEG3350, 10% ethylene glycol, 200mM ammonium formate, 100mM sodium acetate pH=5.0, 50mM maltose.
|
Resolution 2.35 Å
R-free 0.262
|
|
4YXA
Complex of SpaO(SPOA1,2 SeMet) and OrgB(APAR)::T4lysozyme fusion protein
Deposited 2015-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
2–164(163 aa)
Fragment:UNP Residues 1-30,UNP Residues 1-30
|
Mutation:D20N, C54T, C97A,D20N, C54T, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;SpaO(145-213, SeMet) + SpaO (232-297, SeMet) + OrgB(1-30)::T4 lysozyme (native) was concentrated to 18mg/mL, supplemented with 50mM maltose, and crystallized with 25% PEG3350, 200mM ammonium formate, 100mM sodium acetate pH=5.0. Microseeding was employed to enhance crystal uniformity and diffraction. Briefly, crystals to be seeded were harvested in precipitant solution and vortexed in a microfuge tube with a small stir bar for ~60 seconds. The slurry of microseeds was serially dilluted (5-10-fold steps) in precipitant solution and 5 selected microseed-precipitant mixtures were mixed with fresh protein as in a normal hanging drop experiment. Crystals were cryoprotected in 25% PEG3350, 10% ethylene glycol, 200mM ammonium formate, 100mM sodium acetate pH=5.0, 50mM maltose.
|
Resolution 2.35 Å
R-free 0.262
|
|
4YXC
Complex of FliM(SPOA)::FliN fusion protein and FliH(APAR)::T4lysozyme fusion protein
Deposited 2015-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP Residues 1-18
|
Mutation:D20N, C54T, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;FliM(245-334)::FliN(5-137) + FliH(1-18)::T4 lysozyme was concentrated to 17mg/mL and crystallized with 11% PEG400, 100mM sodium potassium phosphate pH=6.5. Crystals were cryoprotected with 40% PEG400, 200mM sodium potassium phosphate pH=6.5.
|
Resolution 2.30 Å
R-free 0.262
|
|
4ZWJ
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Deposited 2015-05-19
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG400, sodium acetate, magnesium acetate
|
Resolution 3.30 Å
R-free 0.293
|
|
4ZWJ
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Deposited 2015-05-19
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG400, sodium acetate, magnesium acetate
|
Resolution 3.30 Å
R-free 0.293
|
|
4ZWJ
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Deposited 2015-05-19
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
2–161(160 aa)
|
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG400, sodium acetate, magnesium acetate
|
Resolution 3.30 Å
R-free 0.293
|
|
4ZWJ
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Deposited 2015-05-19
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
2–161(160 aa)
|
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG400, sodium acetate, magnesium acetate
|
Resolution 3.30 Å
R-free 0.293
|
|
5B2G
Crystal structure of human claudin-4 in complex with C-terminal fragment of Clostridium perfringens enterotoxin
Deposited 2016-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–162(161 aa)
Fragment:UNP residues 2-162,UNP residues 1-183
|
Mutation:R1012G, C1054T, C1097A, I1137R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;75mM MES-NaOH, 20% PEG3350, 7-10% 1,6-hexanediol, 0.002% NaN3, 0.0005% 2,6-di-t-butyl-p-cresol, 150mM NaCl
|
Resolution 3.50 Å
R-free 0.309
|
|
5B2G
Crystal structure of human claudin-4 in complex with C-terminal fragment of Clostridium perfringens enterotoxin
Deposited 2016-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
2–162(161 aa)
Fragment:UNP residues 2-162,UNP residues 1-183
|
Mutation:R1012G, C1054T, C1097A, I1137R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;75mM MES-NaOH, 20% PEG3350, 7-10% 1,6-hexanediol, 0.002% NaN3, 0.0005% 2,6-di-t-butyl-p-cresol, 150mM NaCl
|
Resolution 3.50 Å
R-free 0.309
|
|
5B2G
Crystal structure of human claudin-4 in complex with C-terminal fragment of Clostridium perfringens enterotoxin
Deposited 2016-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
2–162(161 aa)
Fragment:UNP residues 2-162,UNP residues 1-183
|
Mutation:R1012G, C1054T, C1097A, I1137R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;75mM MES-NaOH, 20% PEG3350, 7-10% 1,6-hexanediol, 0.002% NaN3, 0.0005% 2,6-di-t-butyl-p-cresol, 150mM NaCl
|
Resolution 3.50 Å
R-free 0.309
|
|
5B2G
Crystal structure of human claudin-4 in complex with C-terminal fragment of Clostridium perfringens enterotoxin
Deposited 2016-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
2–162(161 aa)
Fragment:UNP residues 2-162,UNP residues 1-183
|
Mutation:R1012G, C1054T, C1097A, I1137R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;75mM MES-NaOH, 20% PEG3350, 7-10% 1,6-hexanediol, 0.002% NaN3, 0.0005% 2,6-di-t-butyl-p-cresol, 150mM NaCl
|
Resolution 3.50 Å
R-free 0.309
|
|
5CGC
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin-4-yl]benzonitrile
Deposited 2015-07-09
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:;E579A N667Y I669A G675M C1054T C1097A T742A S753A,E579A N667Y I669A G675M C1054T C1097A T742A S753A,E579A N667Y I669A G675M C1054T C1097A T742A S753A
;
|
OLA OLEIC ACID × 4
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
51D 3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin-4-yl]benzonitrile × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.8;293.1 K;24-34% V/V PEG400, 0.2 M AMMONIUM PHOSPHATE DIBASIC, 0.1 M MES, PH 6.8,
|
Resolution 3.10 Å
R-free 0.287
|
|
5CGD
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile - (HTL14242)
Deposited 2015-07-09
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:;E579A N667Y I669A G675M C1054T C1097A T742A S753A,E579A N667Y I669A G675M C1054T C1097A T742A S753A,E579A N667Y I669A G675M C1054T C1097A T742A S753A
;
|
OLA OLEIC ACID × 4
51E 3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.8;293.1 K;24-34% V/V PEG400, 0.2 M AMMONIUM PHOSPHATE DIBASIC, 0.1 M MES, PH 6.8,
|
Resolution 2.60 Å
R-free 0.285
|
|
5CXV
Structure of the human M1 muscarinic acetylcholine receptor bound to antagonist Tiotropium
Deposited 2015-07-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
|
Mutation:N110Q, C1052T, C1095A,N110Q, C1052T, C1095A,N110Q, C1052T, C1095A
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
Y01 CHOLESTEROL HEMISUCCINATE × 1
EDO 1,2-ETHANEDIOL × 3
PGE TRIETHYLENE GLYCOL × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;33% PEG 300, 100 mM sodium acetate, and 100 mM Bis-Tris Propane (pH 8.0)
|
Resolution 2.70 Å
R-free 0.282
|
|
5D5A
In meso in situ serial X-ray crystallography structure of the Beta2-adrenergic receptor at 100 K
Deposited 2015-08-10
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:;N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A
;
|
CAU (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol × 1
BU1 1,4-BUTANEDIOL × 2
ACM ACETAMIDE × 1
CLR CHOLESTEROL × 3
PLM PALMITIC ACID × 1
12P DODECAETHYLENE GLYCOL × 1
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;30-35 %(v/v) PEG 400, 0.1-0.2 M Na2SO4, 0.1 M bis-tris propane pH 6.5-7.0 and 5-7 %(v/v) 1,4-butanediol
|
Resolution 2.48 Å
R-free 0.262
|
|
5D5B
In meso X-ray crystallography structure of the Beta2-adrenergic receptor at 100 K
Deposited 2015-08-10
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:;N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A
;
|
CAU (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol × 1
BU1 1,4-BUTANEDIOL × 1
ACM ACETAMIDE × 1
CLR CHOLESTEROL × 3
PLM PALMITIC ACID × 1
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;30-35 %(v/v) PEG 400, 0.1-0.2 M Na2SO4, 0.1 M bis-tris propane pH 6.5-7.0 and 5-7 %(v/v) 1,4-butanediol
|
Resolution 3.80 Å
R-free 0.274
|
|
5D6L
beta2AR-T4L - CIM
Deposited 2015-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–162(162 aa)
|
Mutation:N187E, C54T, C97A,N187E, C54T, C97A,N187E, C54T, C97A
|
SO4 SULFATE ION × 6
CAU (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol × 1
BU1 1,4-BUTANEDIOL × 2
ACM ACETAMIDE × 1
CLR CHOLESTEROL × 3
PLM PALMITIC ACID × 1
12P DODECAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;30 - 35 % Peg 400, 5 -10 % butanediol, 0.1 - 0.35 mM Na sulphate, 0.1 M Bis-Tris pH 7.0.
|
Resolution 3.20 Å
R-free 0.260
|
|
5DGY
Crystal structure of rhodopsin bound to visual arrestin
Deposited 2015-08-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Chain C
2–161(160 aa)
|
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG400
|
Resolution 7.70 Å
R-free 0.335
|
|
5DGY
Crystal structure of rhodopsin bound to visual arrestin
Deposited 2015-08-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–161(160 aa)
Chain D
2–161(160 aa)
|
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
Mutation:R12G, C54T, C97A , I137R,N2C, E113Q, M257Y, N282C,L374A, V375A, F376A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG400
|
Resolution 7.70 Å
R-free 0.335
|
|
5DSG
Structure of the M4 muscarinic acetylcholine receptor (M4-mT4L) bound to tiotropium
Deposited 2015-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–11(10 aa)
Chain A
61–161(101 aa)
|
Not recorded
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
OLA OLEIC ACID × 3
EDT {[-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-CARBOXYMETHYL-AMINO}-ACETIC ACID × 1
P6G HEXAETHYLENE GLYCOL × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;Reconstituted in 10:1 monoolein:cholesterol mix. Precipitant solution: 20 - 40% PEG300, 100 mM MES, pH 5.5 - 7.5, and 10 - 150 mM EDTA, pH 8.0
|
Resolution 2.60 Å
R-free 0.240
|
|
5DSG
Structure of the M4 muscarinic acetylcholine receptor (M4-mT4L) bound to tiotropium
Deposited 2015-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–11(10 aa)
Chain B
61–161(101 aa)
|
Not recorded
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 1
OLA OLEIC ACID × 2
P6G HEXAETHYLENE GLYCOL × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
PG6 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;Reconstituted in 10:1 monoolein:cholesterol mix. Precipitant solution: 20 - 40% PEG300, 100 mM MES, pH 5.5 - 7.5, and 10 - 150 mM EDTA, pH 8.0
|
Resolution 2.60 Å
R-free 0.240
|
|
5DSG
Structure of the M4 muscarinic acetylcholine receptor (M4-mT4L) bound to tiotropium
Deposited 2015-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–11(10 aa)
Chain A
61–161(101 aa)
Chain B
2–11(10 aa)
Chain B
61–161(101 aa)
|
Not recorded
|
0HK (1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane × 2
OLA OLEIC ACID × 5
EDT {[-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-CARBOXYMETHYL-AMINO}-ACETIC ACID × 1
P6G HEXAETHYLENE GLYCOL × 2
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 5
PG6 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;Reconstituted in 10:1 monoolein:cholesterol mix. Precipitant solution: 20 - 40% PEG300, 100 mM MES, pH 5.5 - 7.5, and 10 - 150 mM EDTA, pH 8.0
|
Resolution 2.60 Å
R-free 0.240
|
|
5EE7
Crystal structure of the human glucagon receptor (GCGR) in complex with the antagonist MK-0893
Deposited 2015-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–160(160 aa)
|
Mutation:;G154A R173A A182L S190A G223A M276A E362F G207E K344A F387A V193F,G154A R173A A182L S190A G223A M276A E362F G207E K344A F387A V193F,G154A R173A A182L S190A G223A M276A E362F G207E K344A F387A V193F
;
|
5MV 3-[[4-[(1~{S})-1-[3-[3,5-bis(chloranyl)phenyl]-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]phenyl]carbonylamino]propanoic acid × 1
OLA OLEIC ACID × 14
PE5 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL × 1
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293.15 K;ADA BUFFER, SODIUM POTASSIUM TARTRATE, PEG 400
|
Resolution 2.50 Å
R-free 0.263
|
|
5EUT
Crystal structure of phosphatidyl inositol 4-kinase II alpha in the apo state
Deposited 2015-11-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–163(162 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;12.5% w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v MPD, 0.1 M bicine/Trizma base pH 8.5
|
Resolution 2.80 Å
R-free 0.289
|
|
5EWX
Fusion protein of T4 lysozyme and B4 domain of protein A from staphylococcal aureus with chemical cross-linker EY-CBS
Deposited 2015-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–35(35 aa)
Fragment:UNP RESIDUES 1-35, 219-266, 38-164
Chain A
38–164(127 aa)
Fragment:UNP RESIDUES 1-35, 219-266, 38-164
|
Mutation:A1212V, G1240A, E1258C, K1261A, L1262A, N40C, C54T, C97A, K162A
Mutation:A1212V, G1240A, E1258C, K1261A, L1262A, N40C, C54T, C97A, K162A
|
EYC 2,2'-ethyne-1,2-diylbis{5-[(chloroacetyl)amino]benzenesulfonic acid} × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 7.5;277 K;1.84M Na/K Phosphate, pH 7.5
|
Resolution 2.60 Å
R-free 0.253
|
|
5EWX
Fusion protein of T4 lysozyme and B4 domain of protein A from staphylococcal aureus with chemical cross-linker EY-CBS
Deposited 2015-11-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–35(35 aa)
Fragment:UNP RESIDUES 1-35, 219-266, 38-164
Chain B
38–164(127 aa)
Fragment:UNP RESIDUES 1-35, 219-266, 38-164
|
Mutation:A1212V, G1240A, E1258C, K1261A, L1262A, N40C, C54T, C97A, K162A
Mutation:A1212V, G1240A, E1258C, K1261A, L1262A, N40C, C54T, C97A, K162A
|
EYC 2,2'-ethyne-1,2-diylbis{5-[(chloroacetyl)amino]benzenesulfonic acid} × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 7.5;277 K;1.84M Na/K Phosphate, pH 7.5
|
Resolution 2.60 Å
R-free 0.253
|
|
5G27
Structure of Spin-labelled T4 lysozyme mutant L118C-R1 at Room Temperature
Deposited 2016-04-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
CL CHLORIDE ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
PROTEIN WAS CRYSTALLIZED FROM 2.0 M K2HPO4/NAH2PO4, 250 MM NACL, 0.04 % AZIDE, 20 MM DITHIODIETHANOL, PH 7.2
|
Resolution 1.61 Å
R-free 0.169
|
|
5JDT
Structure of Spin-labelled T4 lysozyme mutant L118C-R1 at 100K
Deposited 2016-04-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
CL CHLORIDE ION × 3
BME BETA-MERCAPTOETHANOL × 1
AZI AZIDE ION × 2
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;291 K;2.0 M NA/K PHOSPHATE, 240 mM NACL, 40 mM 2-HYDROXYETHYL DISULFIDE, PH 6.8
|
Resolution 1.00 Å
R-free 0.130
|
|
5JEA
Structure of a cytoplasmic 11-subunit RNA exosome complex including Ski7, bound to RNA
Deposited 2016-04-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 11
PDB declaration: dodecameric
|
Chain K
1–164(164 aa)
|
Not recorded
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 7
NA SODIUM ION × 4
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;27 % 2-Methyl-2,4-pentanediol (MPD), 0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) pH 6 and 10 mM CaCl2.
|
Resolution 2.65 Å
R-free 0.259
|
|
5JGN
Spin-Labeled T4 Lysozyme Construct I9V1
Deposited 2016-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I9C, C54T, C97A
|
CL CHLORIDE ION × 4
K POTASSIUM ION × 1
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;297 K;sodium/potassium phosphate, sodium chloride, hexane-1,6-diol, 2-propanol
|
Resolution 1.53 Å
R-free 0.172
|
|
5JGR
Spin-Labeled T4 Lysozyme Construct K43V1
Deposited 2016-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:K43C, C54T, C97A
|
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 1
CL CHLORIDE ION × 3
PO4 PHOSPHATE ION × 1
K POTASSIUM ION × 1
HEZ HEXANE-1,6-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.2;297 K;sodium/potassium phosphate, sodium chloride, hexane-1,6-diol, 2-propanol
|
Resolution 1.46 Å
R-free 0.193
|
|
5JGU
Spin-Labeled T4 Lysozyme Construct R119V1
Deposited 2016-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, R119C
|
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 3
K POTASSIUM ION × 1
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;297 K;sodium/potassium phosphate, sodium chloride, hexane-1,6-diol, 2-propanol
|
Resolution 1.47 Å
R-free 0.175
|
|
5JGV
Spin-Labeled T4 Lysozyme Construct A73V1
Deposited 2016-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, A73C, C97A
|
CL CHLORIDE ION × 5
K POTASSIUM ION × 1
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 1
HEZ HEXANE-1,6-DIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;sodium/potassium phosphate, sodium chloride, hexane-1,6-diol, 2-propanol
|
Resolution 1.73 Å
R-free 0.189
|
|
5JGX
Spin-Labeled T4 Lysozyme Construct V131V1
Deposited 2016-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, V131C
|
CL CHLORIDE ION × 3
K POTASSIUM ION × 1
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;293 K;sodium/potassium phosphate, sodium chloride, hexane-1,6-diol, 2-propanol
|
Resolution 1.53 Å
R-free 0.189
|
|
5JGZ
Spin-Labeled T4 Lysozyme Construct T151V1
Deposited 2016-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T, C97A, T151C
|
CL CHLORIDE ION × 1
K POTASSIUM ION × 1
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 1
PO4 PHOSPHATE ION × 1
HEZ HEXANE-1,6-DIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;sodium/potassium phosphate, sodium chloride, hexane-1,6-diol, 2-propanol
|
Resolution 1.53 Å
R-free 0.195
|
|
5JQH
Structure of beta2 adrenoceptor bound to carazolol and inactive-state stabilizing nanobody, Nb60
Deposited 2016-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:UNP RESIDUES 2-161, UNP RESIDEUS 30-348
|
Mutation:C919T, C962A, M1096T, M1098T, N1187E, C1265A,C919T, C962A, M1096T, M1098T, N1187E, C1265A
|
CAU (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol × 1
CLR CHOLESTEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.5;293 K;100 mM HEPES pH 7.5, 20 mM EDTA, and 19-23% PEG300
|
Resolution 3.20 Å
R-free 0.290
|
|
5JQH
Structure of beta2 adrenoceptor bound to carazolol and inactive-state stabilizing nanobody, Nb60
Deposited 2016-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–161(160 aa)
Fragment:UNP RESIDUES 2-161, UNP RESIDEUS 30-348
|
Mutation:C919T, C962A, M1096T, M1098T, N1187E, C1265A,C919T, C962A, M1096T, M1098T, N1187E, C1265A
|
CAU (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol × 1
CLR CHOLESTEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.5;293 K;100 mM HEPES pH 7.5, 20 mM EDTA, and 19-23% PEG300
|
Resolution 3.20 Å
R-free 0.290
|
|
5JWS
T4 Lysozyme L99A with 1-Hydro-2-ethyl-1,2-azaborine Bound
Deposited 2016-05-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
6OQ 2-ethyl-1,2-dihydro-1,2-azaborinine × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277.15 K;2.2 M sodium/potassium phosphate, pH 7.0, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.65 Å
R-free 0.233
|
|
5JWT
T4 Lysozyme L99A/M102Q with Benzene Bound
Deposited 2016-05-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
BNZ BENZENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;277.15 K;2.2 M sodium/potassium phosphate, pH 6.9, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.41 Å
R-free 0.243
|
|
5JWU
T4 Lysozyme L99A/M102Q with 1,2-Dihydro-1,2-azaborine Bound
Deposited 2016-05-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
B20 1,2-dihydro-1,2-azaborinine × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277.15 K;2.1 M sodium/potassium phosphate, pH 7.0, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.70 Å
R-free 0.251
|
|
5JWV
T4 Lysozyme L99A/M102Q with Ethylbenzene Bound
Deposited 2016-05-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
PYJ PHENYLETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.1;277.15 K;2.2 M sodium/potassium phosphate, pH 7.1, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.30 Å
R-free 0.203
|
|
5JWW
T4 Lysozyme L99A/M102Q with 1-Hydro-2-ethyl-1,2-azaborine Bound
Deposited 2016-05-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
6OQ 2-ethyl-1,2-dihydro-1,2-azaborinine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277.15 K;2.1 M sodium/potassium phosphate, pH 6.8, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.47 Å
R-free 0.249
|
|
5KGR
Spin-Labeled T4 Lysozyme Construct I9V1/V131V1 (30 days)
Deposited 2016-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:I9C, C54T, C97A, V131C
|
V1A S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate × 2
HEZ HEXANE-1,6-DIOL × 1
CL CHLORIDE ION × 3
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;2 M sodium/potassium phosphate, 150 mM sodium chloride, 100 mM 1,2-hexanediol, 3% 2-propanol
|
Resolution 1.47 Å
R-free 0.189
|
|
5KHZ
PSEUDO T4 LYSOZYME
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291.15 K;2.0M KPO4, 50MM 2-HYDROXYETHYLDISULFIDE, 50MM 2-MERCAPTOETHANOL, PH 6.9
|
Resolution 1.49 Å
R-free 0.201
|
|
5KI1
PSEUDO T4 LYSOZYME MUTANT - Y18F
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;291.15 K;2.4M KPO4, 50MM 2-HYDROXYETHYLDISULFIDE, 50MM 2-MERCAPTOETHANOL, PH 6.7
|
Resolution 1.46 Å
R-free 0.207
|
|
5KI2
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-METHYL
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;291.15 K;2.2M KPO4, 50MM 2-HYDROXYETHYLDISULFIDE, 50MM 2-MERCAPTOETHANOL, PH 6.8
|
Resolution 1.50 Å
R-free 0.221
|
|
5KI3
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-BR
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;291.15 K;2.0M KPO4, 50MM 2-HYDROXYETHYLDISULFIDE, 50MM 2-MERCAPTOETHANOL, PH 6.7
|
Resolution 1.65 Å
R-free 0.250
|
|
5KI8
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-BR
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291.15 K;2.4M KPO4, 50MM 2-HYDROXYETHYLDISULFIDE, 50MM 2-MERCAPTOETHANOL, PH 6.9
|
Resolution 1.55 Å
R-free 0.210
|
|
5KIG
PSEUDO T4 LYSOZYME MUTANT - Y88F
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291.15 K;2.0M KPO4, 50MM 2-HYDROXYETHYLDISULFIDE, 50MM 2-MERCAPTOETHANOL, PH6.9
|
Resolution 1.50 Å
R-free 0.196
|
|
5KII
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-METHYL
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291.15 K;2.0M KP04, 50mM 2-HYDROXYETHYLDISULFIDE, 50mM 2-MERCAPTOETHANOL, PH 6.9
|
Resolution 1.56 Å
R-free 0.223
|
|
5KIM
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-I
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291.15 K;2.0M KPO4, 50mM 2-HYDROXYETHYLDISULFID, 50mM 2-MERCAPTOETHANOL, PH6.9
|
Resolution 1.50 Å
R-free 0.184
|
|
5KIO
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-I
Deposited 2016-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;291.15 K;2.0M KPO4, 50MM 2-HYDROXYETHYLDISULFIDE, 50MM 2-MERCAPTOETHANOL, PH 6.7
|
Resolution 1.63 Å
R-free 0.237
|
|
5LWO
Structure of Spin-labelled T4 lysozyme mutant L115C-R119C-R1 at 100K
Deposited 2016-09-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:C54T C97A L118C T115C R119C
|
RXR [2,2,5,5-tetramethyl-3,4-bis(sulfanylmethyl)-2,5-dihydro-1H-pyrrol-1-yl]oxidanyl radical × 1
CL CHLORIDE ION × 4
HED 2-HYDROXYETHYL DISULFIDE × 1
PO4 PHOSPHATE ION × 1
BME BETA-MERCAPTOETHANOL × 1
K POTASSIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;2.0 M NA/K PHOSPHATE, 240 mM NACL, 40 mM 2-HYDROXYETHYL DISULFIDE, PH 6.8
|
Resolution 1.18 Å
R-free 0.164
|
|
5LZM
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STRENGTHS
Deposited 1991-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
5T04
STRUCTURE OF CONSTITUTIVELY ACTIVE NEUROTENSIN RECEPTOR
Deposited 2016-08-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Fragment:unp residues 43-268; 2-161; 297-396,unp residues 43-268; 2-161; 297-396,unp residues 43-268; 2-161; 297-396
|
Mutation:;A86L, G215A, F358A, V360A, R12G, C54T, C97A, Q122N, Q123N, I137R,A86L, G215A, F358A, V360A, R12G, C54T, C97A, Q122N, Q123N, I137R,A86L, G215A, F358A, V360A, R12G, C54T, C97A, Q122N, Q123N, I137R
;
|
TCE 3,3',3''-phosphanetriyltripropanoic acid × 1
GOL GLYCEROL × 1
PEG DI(HYDROXYETHYL)ETHER × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;13-16% (v/v) PEG 400,
80 mM TrisHCl pH 8.5-9.0,
1.9 mM TCEP,
68-91 mM lithium acetate,
0.9 mM Neurotensin
|
Resolution 3.30 Å
R-free 0.283
|
|
5TZR
GPR40 in complex with partial agonist MK-8666
Deposited 2016-11-22
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:L42A, F88A, G103A, Y202F, R1012G, C1054T, C1097A, I1137R
|
NA SODIUM ION × 1
MK6 (5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid × 1
MLI MALONATE ION × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 8
1PE PENTAETHYLENE GLYCOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.7;293 K;25-28%PEG 400, 0.2M sodium malonate, 0.1M Tris pH7.7
|
Resolution 2.20 Å
R-free 0.228
|
|
5TZY
GPR40 in complex with AgoPAM AP8 and partial agonist MK-8666
Deposited 2016-11-22
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:;L42A, G103A, Y202F, R1012G, C1054T, C1097A, I1137R,L42A, G103A, Y202F, R1012G, C1054T, C1097A, I1137R,L42A, G103A, Y202F, R1012G, C1054T, C1097A, I1137R
;
|
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
MK6 (5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid × 1
7OS (2S,3R)-3-cyclopropyl-3-[(2R)-2-(1-{(1S)-1-[5-fluoro-2-(trifluoromethoxy)phenyl]ethyl}piperidin-4-yl)-3,4-dihydro-2H-1-benzopyran-7-yl]-2-methylpropanoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.5;293 K;22% PEG 400, 0.37M potassium nitrate, 0.1M MES pH6.5
|
Resolution 3.22 Å
R-free 0.287
|
|
5VEW
Structure of the human GLP-1 receptor complex with PF-06372222
Deposited 2017-04-05
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
OLA OLEIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 2.70 Å
R-free 0.246
|
|
5VEW
Structure of the human GLP-1 receptor complex with PF-06372222
Deposited 2017-04-05
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 2.70 Å
R-free 0.246
|
|
5VEX
Structure of the human GLP-1 receptor complex with NNC0640
Deposited 2017-04-05
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
97V 4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium acetate, pH 5.0-5.8, 38-40% PEG400
|
Resolution 3.00 Å
R-free 0.256
|
|
5VEX
Structure of the human GLP-1 receptor complex with NNC0640
Deposited 2017-04-05
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
97V 4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium acetate, pH 5.0-5.8, 38-40% PEG400
|
Resolution 3.00 Å
R-free 0.256
|
|
5WF5
Agonist bound human A2a adenosine receptor with D52N mutation at 2.60 A resolution
Deposited 2017-07-11
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:R1012G C1054T C1097A I1137R
|
UKA 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;296 K;100 mM sodium citrate pH 5, 24-27% (v/v)
polyethylene glycol (PEG) 400, 30-80 mM MgCl 2 , 5% (v/v) Jeffamine M-600 pH 7 (Hampton)
|
Resolution 2.60 Å
R-free 0.251
|
|
5WF6
Agonist bound human A2a adenosine receptor with S91A mutation at 2.90 A resolution
Deposited 2017-07-11
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:R1012G, C1054T, C1097A, I1137R
|
UKA 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;100 mM sodium citrate pH 5, 24-27% (v/v)
polyethylene glycol (PEG) 400, 30-80 mM MgCl 2 , 5% (v/v) Jeffamine M-600 pH 7 (Hampton)
|
Resolution 2.90 Å
R-free 0.288
|
|
5X93
Human endothelin receptor type-B in complex with antagonist K-8794
Deposited 2017-03-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
61–161(101 aa)
|
Mutation:R124Y,D154A,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A
|
K87 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]oxy-N-(2,6-dimethylphenyl)propanamide × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 11
CLR CHOLESTEROL × 1
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500 DME, (NH4)2SO4, MOPS
|
Resolution 2.20 Å
R-free 0.239
|
|
5XPR
Human endothelin receptor type-B in complex with antagonist bosentan
Deposited 2017-06-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
61–161(101 aa)
|
Mutation:R124Y,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A
|
K86 4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide × 1
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500 DME, Na2SO4, MOPS
|
Resolution 3.60 Å
R-free 0.297
|
|
5XSZ
Crystal structure of zebrafish lysophosphatidic acid receptor LPA6
Deposited 2017-06-16
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:E1011N,R1012G,D1020N,C1054T,C1097A,I1137R
|
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;298 K;MES, PEG 400, NaH2PO4, 1,4-butanediol
|
Resolution 3.20 Å
R-free 0.263
|
|
5YQR
Crystal structure of the PH-like domain of Lam6
Deposited 2017-11-07
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:R12G,D20N, C54T, C97A, I137R
|
2PE NONAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;0.1M HEPES-HCl pH 7.0, 10% PEG8000, 0.1M Na3Citrate
|
Resolution 2.40 Å
R-free 0.266
|
|
5ZKQ
Crystal structure of the human platelet-activating factor receptor in complex with ABT-491
Deposited 2018-03-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–11(10 aa)
Chain A
61–161(101 aa)
Chain B
2–11(10 aa)
Chain B
61–161(101 aa)
|
Mutation:F116Y, N169D, A230D,C97A, I137R, A230D, V234A, D289N
Mutation:F116Y, N169D, A230D,C97A, I137R, A230D, V234A, D289N
Mutation:F116Y, N169D, A230D,C97A, I137R, A230D, V234A, D289N
Mutation:F116Y, N169D, A230D,C97A, I137R, A230D, V234A, D289N
|
9EU 4-ethynyl-3-{3-fluoro-4-[(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)methyl]benzene-1-carbonyl}-N,N-dimethyl-1H-indole-1-carboxamide × 2
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 7
ZN ZINC ION × 2
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;HEPES, PEG 400, MgSO4
|
Resolution 2.90 Å
R-free 0.235
|
|
6BG3
Structure of (3S,4S)-1-benzyl-4-(3-(3-(trifluoromethyl)phenyl)ureido)piperidin-3-yl acetate bound to DCN1
Deposited 2017-10-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
Fragment:PONY
|
Not recorded
|
DOJ N-{(3S,4S)-1-benzyl-3-[(1S)-1-hydroxyethoxy]piperidin-4-yl}-N'-[3-(trifluoromethyl)phenyl]urea × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;277 K;6% PEG3350, 0.2M NH4Br
|
Resolution 1.05 Å
R-free 0.173
|
|
6BG5
Structure of 1-(benzo[d][1,3]dioxol-5-ylmethyl)-1-(1-propylpiperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)urea bound to DCN1
Deposited 2017-10-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
Fragment:PONY
|
Not recorded
|
DQD N-[(2H-1,3-benzodioxol-5-yl)methyl]-N-(1-propylpiperidin-4-yl)-N'-[3-(trifluoromethyl)phenyl]urea × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;277 K;6% PEG3350, 0.2M NH4Br
|
Resolution 1.10 Å
R-free 0.172
|
|
6FFH
Crystal Structure of mGluR5 in complex with Fenobam at 2.65 A
Deposited 2018-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:MGLUR5
|
Mutation:C54T C97A E579A N667Y I669A G675M T742A S753A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
OLA OLEIC ACID × 5
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
D7W 1-(3-chlorophenyl)-3-(3-methyl-5-oxidanylidene-4~{H}-imidazol-2-yl)urea × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.8;293.1 K;24-34% V/V PEG400, 0.2 M AMMONIUM PHOSPHATE DIBASIC, 0.1 M MES, PH 6.8
|
Resolution 2.65 Å
R-free 0.267
|
|
6FFI
Crystal Structure of mGluR5 in complex with MMPEP at 2.2 A
Deposited 2018-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–162(161 aa)
Fragment:MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5,MGLUR5
|
Mutation:;E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A,E579A N667Y I669A G675M T742A S753A
;
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
OLA OLEIC ACID × 7
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
D8B 2-[2-(3-methoxyphenyl)ethynyl]-6-methyl-pyridine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.8;293.1 K;24-34% V/V PEG400, 0.2 M AMMONIUM PHOSPHATE DIBASIC, 0.1 M MES, PH 6.8
|
Resolution 2.20 Å
R-free 0.269
|
|
6IIH
crystal structure of mitochondrial calcium uptake 2(MICU2)
Deposited 2018-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–161(161 aa)
Chain B
1–161(161 aa)
|
Mutation:C54T, C97A
Mutation:C54T, C97A
|
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.16;293 K;100 mM Sodium phosphate monobasic , 100 mM potassium phosphate monobasic , 100 mM MES, 6.0 and 1M sodium chloride
|
Resolution 1.96 Å
R-free 0.227
|
|
6K1Q
Human endothelin receptor type-B in complex with inverse agonist IRL2500
Deposited 2019-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
61–161(101 aa)
|
Mutation:;R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A
;
|
D2U (2~{S})-2-[[(2~{R})-2-[(3,5-dimethylphenyl)carbonyl-methyl-amino]-3-(4-phenylphenyl)propanoyl]amino]-3-(1~{H}-indol-3-yl)propanoic acid × 1
PO4 PHOSPHATE ION × 4
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.5;293 K;30% PEG300, 150 mM NaH2PO4,10 mM TCEP, 100 mM Bis-tris
|
Resolution 2.70 Å
R-free 0.265
|
|
6KJV
Structure of thermal-stabilised(M9) human GLP-1 receptor transmembrane domain
Deposited 2019-07-23
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:S193C,I196F,S225A,S271A,I317C,G318I,K346A,C347F,G361C,205-214deletion,R1011G,C1053T,C1096A,I1136R
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 2.80 Å
R-free 0.280
|
|
6KJV
Structure of thermal-stabilised(M9) human GLP-1 receptor transmembrane domain
Deposited 2019-07-23
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Mutation:S193C,I196F,S225A,S271A,I317C,G318I,K346A,C347F,G361C,205-214deletion,R1011G,C1053T,C1096A,I1136R
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 2.80 Å
R-free 0.280
|
|
6KK1
Structure of thermal-stabilised(M8) human GLP-1 receptor transmembrane domain
Deposited 2019-07-23
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:;I196F,S225A,S271A,I317C,G318I,K346A,C347F,G361C,205-214deletion,R1011G,C1053T,C1096A,I1136R,I196F,S225A,S271A,I317C,G318I,K346A,C347F,G361C,205-214deletion
;
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 2.80 Å
R-free 0.290
|
|
6KK1
Structure of thermal-stabilised(M8) human GLP-1 receptor transmembrane domain
Deposited 2019-07-23
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Mutation:;I196F,S225A,S271A,I317C,G318I,K346A,C347F,G361C,205-214deletion,R1011G,C1053T,C1096A,I1136R,I196F,S225A,S271A,I317C,G318I,K346A,C347F,G361C,205-214deletion
;
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 2.80 Å
R-free 0.290
|
|
6KK7
Structure of thermal-stabilised(M6) human GLP-1 receptor transmembrane domain
Deposited 2019-07-23
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:S225A,I317C,G318I,K346A,C347F,G361C,205-214deletion,R1011G,C1053T,C1096A,I1136R
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 3.10 Å
R-free 0.303
|
|
6KK7
Structure of thermal-stabilised(M6) human GLP-1 receptor transmembrane domain
Deposited 2019-07-23
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–161(160 aa)
|
Mutation:S225A,I317C,G318I,K346A,C347F,G361C,205-214deletion,R1011G,C1053T,C1096A,I1136R
|
97Y N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.4-0.45 M ammonium acetate, 0.1 M sodium cacodylate, pH 6.2-6.6, 35-38% PEG400, 3% w/v aminohexanoic acid
|
Resolution 3.10 Å
R-free 0.303
|
|
6LZM
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STRENGTHS
Deposited 1991-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
BME BETA-MERCAPTOETHANOL × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
6M9T
Crystal structure of EP3 receptor bound to misoprostol-FA
Deposited 2018-08-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
Fragment:EP3 UNP residues 2-259,273-353 with intervening lysozyme
|
Not recorded
|
J9P (11alpha,12alpha,13E,16S)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid × 1
SO4 SULFATE ION × 4
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
OLA OLEIC ACID × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;100 mM sodium citrate, pH 3.8-4.2, 10-35 mM magnesium sulfate, 20-23% v/v PEG400, 2.5% Jeffamine M-600
|
Resolution 2.50 Å
R-free 0.242
|
|
6QAJ
Structure of the tripartite motif of KAP1/TRIM28
Deposited 2018-12-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
Chain B
2–161(160 aa)
|
Not recorded
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;291 K;15% (w/v) PEG 3350, 75 mM MgCl2, 0.1 M HEPES pH 7.5
|
Resolution 2.90 Å
R-free 0.291
|
|
6WSK
Crystal Structure of the Cannabinoid Receptor 1 Interacting Protein 1a (CRIP1a)
Deposited 2020-05-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–161(161 aa)
|
Mutation:E11Q, D20N, C54T, C97A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;30 mg/mL, 0.1 M sodium citrate (pH 4-5.5), and 0.3-0.6 ammonium sulfate
|
Resolution 1.55 Å
R-free 0.225
|
|
6XYR
Structure of the T4Lnano fusion protein
Deposited 2020-01-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–164(163 aa)
|
Not recorded
|
CA CALCIUM ION × 5
GOL GLYCEROL × 5
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;8% PEG 8000, 200 mM LiCl2, 100 mM Tris pH 8.0, 15% Glycerol
|
Resolution 2.08 Å
R-free 0.236
|
|
6ZFZ
Structure of M1-StaR-T4L in complex with 77-LH-28-1 at 2.17A
Deposited 2020-06-18
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:F27A,T32A,V46L,L64A,T95A,W101A,S112A,A143L,A196T,K362A,A364L,S411A
|
QJT 1-[3-(4-butylpiperidin-1-yl)propyl]-3,4-dihydroquinolin-2-one × 1
OLA OLEIC ACID × 8
PO4 PHOSPHATE ION × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
PGE TRIETHYLENE GLYCOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.1M NaHEPES pH 7.4-7.8, 0.1M di-ammonium hydrogenphosphate, 30-38% PEG300
|
Resolution 2.17 Å
R-free 0.242
|
|
6ZG4
Structure of M1-StaR-T4L in complex with HTL0009936 at 2.35A
Deposited 2020-06-18
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:F27A,T32A,V46L,L64A,T95A,W101A,S112A,A143L,A196T,K362A,A364L,S411A
|
QK8 ethyl (4~{S})-4-[4-[(1-methylcyclobutyl)carbamoyl]piperidin-1-yl]azepane-1-carboxylate × 1
OLA OLEIC ACID × 11
PGE TRIETHYLENE GLYCOL × 1
PO4 PHOSPHATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.1M NaHEPES pH 7.4-7.8, 0.1M di-Ammonium hydrogenphosphate, 30-38% PEG300
|
Resolution 2.33 Å
R-free 0.234
|
|
6ZG9
Structure of M1-StaR-T4L in complex with GSK1034702 at 2.5A
Deposited 2020-06-18
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:F27A,T32A,V46L,L64A,T95A,W101A,S112A,A143L,A196T,K362A,A364L,S411A
|
QK2 7-fluoranyl-5-methyl-3-[1-(oxan-4-yl)piperidin-4-yl]-1~{H}-benzimidazol-2-one × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
OLA OLEIC ACID × 6
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.1 NaHEPES pH 7.4-7.8, 0.1M di-ammonium hydrogenohosphate, 30-38% PEG300
|
Resolution 2.50 Å
R-free 0.242
|
|
6ZX9
Crystal structure of SIV Vpr,fused to T4 lysozyme, isolated from moustached monkey, bound to human DDB1 and human DCAF1 (amino acid residues 1046-1396)
Deposited 2020-07-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2–164(163 aa)
|
Not recorded
|
GOL GLYCEROL × 8
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;8-10% PEG 4000 (w/v), 200 mM MgCl2, 100 mM HEPES-NaOH, pH 7.0-8.2.
|
Resolution 2.52 Å
R-free 0.260
|
|
7F8U
Crystal structure of the cholecystokinin receptor CCKAR in complex with lintitript
Deposited 2021-07-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
1OE 2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]ethanoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.1 M HEPES, pH7.5, 25% PEG400, 250 mM sodium tartrate ,1% 1,2 -butanediol
|
Resolution 2.80 Å
R-free 0.253
|
|
7F8X
Crystal structure of the cholecystokinin receptor CCKAR in complex with NN9056
Deposited 2021-07-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
|
Mutation:F130W,C1251G,C1336A,C1293T,I1376R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;100 mM HEPES,7.5, 10 (v/v) PPG400 and 100 mM ammonium acetate
|
Resolution 3.00 Å
R-free 0.261
|
|
7F8Y
Crystal structure of the cholecystokinin receptor CCKAR in complex with devazepide
Deposited 2021-07-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:D87N,F130W,R1251G,G1293T,C1336A,I385R
|
1OZ N-[(3S)-1-methyl-2-oxidanylidene-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;0.1 M HEPES, pH 7.5, 25% (v/v) PEG400 and 350 mM ammonium acetate
|
Resolution 2.50 Å
R-free 0.268
|
|
7L37
T4 Lysozyme L99A - Apo - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.44 Å
R-free 0.184
|
|
7L38
T4 Lysozyme L99A - Apo - cryo
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.33 Å
R-free 0.200
|
|
7L39
T4 Lysozyme L99A - toluene - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
CL CHLORIDE ION × 1
MBN TOLUENE × 1
BME BETA-MERCAPTOETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.35 Å
R-free 0.167
|
|
7L3A
T4 Lysozyme L99A - toluene - cryo
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
MBN TOLUENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.11 Å
R-free 0.203
|
|
7L3B
T4 Lysozyme L99A - iodobenzene - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 2
CL CHLORIDE ION × 1
PIH iodobenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.27 Å
R-free 0.167
|
|
7L3C
T4 Lysozyme L99A - o-xylene - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
CL CHLORIDE ION × 1
BME BETA-MERCAPTOETHANOL × 1
OXE ORTHO-XYLENE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.31 Å
R-free 0.177
|
|
7L3D
T4 Lysozyme L99A - 3-iodotoluene - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 2
CL CHLORIDE ION × 1
XQJ 1-iodo-3-methylbenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.35 Å
R-free 0.162
|
|
7L3E
T4 Lysozyme L99A - 3-iodotoluene - cryo
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 1
CL CHLORIDE ION × 1
XQJ 1-iodo-3-methylbenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.13 Å
R-free 0.153
|
|
7L3F
T4 Lysozyme L99A - 4-iodotoluene - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
CL CHLORIDE ION × 1
XQM 1-iodo-4-methylbenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.49 Å
R-free 0.170
|
|
7L3G
T4 Lysozyme L99A - 4-iodotoluene - cryo
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 1
CA CALCIUM ION × 1
XQM 1-iodo-4-methylbenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.27 Å
R-free 0.174
|
|
7L3H
T4 Lysozyme L99A - ethylbenzene - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 1
CL CHLORIDE ION × 1
PYJ PHENYLETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.39 Å
R-free 0.172
|
|
7L3I
T4 Lysozyme L99A - propylbenzene - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
CL CHLORIDE ION × 1
3H0 propylbenzene × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.46 Å
R-free 0.168
|
|
7L3J
T4 Lysozyme L99A - benzylacetate - RT
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 1
CL CHLORIDE ION × 1
J0Z benzyl acetate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.49 Å
R-free 0.173
|
|
7L3K
T4 Lysozyme L99A - benzylacetate - cryo
Deposited 2020-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Mutation:R12G/I137R/L99A
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
BME BETA-MERCAPTOETHANOL × 1
CL CHLORIDE ION × 1
J0Z benzyl acetate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;Crystals were grown from a 10 mg/mL frozen protein solution by the hanging drop method at 291-293K, with a 1:1 drop ratio of protein to solution and over a well solution of 0.1 M Tris-hydrochloride (pH 8), 20%-26% (w/v) PEG 4000, 70-170 mM lithium citrate, 8%-18% 2-propanol, 50 mM 2-mercaptoethanol, and 50 mM 2-hydroxyethyl disulfide
|
Resolution 1.11 Å
R-free 0.167
|
|
7LZM
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STRENGTHS
Deposited 1991-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
7MI3
Signal subtracted reconstruction of AAA2, AAA3, and AAA4 domains of dynein in the presence of a pyrazolo-pyrimidinone-based compound, Model 4
Deposited 2021-04-16
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
ZG7 (8S)-6-(3-bromophenoxy)-2-[1-(4-chlorophenyl)cyclopropyl]-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carbonitrile × 2
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
7MI6
Yeast dynein motor domain in the presence of a pyrazolo-pyrimidinone-based compound, Model 1
Deposited 2021-04-16
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:E1849Q
|
ZG7 (8S)-6-(3-bromophenoxy)-2-[1-(4-chlorophenyl)cyclopropyl]-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carbonitrile × 2
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.90 Å
|
|
7MI8
Signal subtracted reconstruction of AAA5 and AAA6 domains of dynein in the presence of a pyrazolo-pyrimidinone-based compound, Model 5
Deposited 2021-04-16
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.70 Å
|
|
7P2L
thermostabilised 7TM domain of human mGlu5 receptor bound to photoswitchable ligand alloswitch-1
Deposited 2021-07-06
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:E579A,N667Y,I669A,G675M,T742A,S753A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
4YI 2-chloranyl-~{N}-[2-methoxy-4-[(~{E})-pyridin-2-yldiazenyl]phenyl]benzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;295 K;0.15-0.25 M ammonium phosphate dibasic, 22-24 % polyethylene glycol 400, either with 0.10 M 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.7-6.8 or 0.1 M HEPES pH 6.8
|
Resolution 2.54 Å
R-free 0.285
|
|
7RX9
Structure of autoinhibited P-Rex1
Deposited 2021-08-22
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;1.8 M (NH4)2SO4, 0.05 MES pH 6.0
|
Resolution 3.22 Å
R-free 0.262
|
|
7SJ6
T4 Lysozyme L99A/M102H with 1,2-Azaborine bound
Deposited 2021-10-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–164(164 aa)
|
Not recorded
|
B20 1,2-dihydro-1,2-azaborinine × 1
SO4 SULFATE ION × 2
BME BETA-MERCAPTOETHANOL × 1
HED 2-HYDROXYETHYL DISULFIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277.15 K;Crystals were grown from a 5 mg/ml solution of the protein by the hanging drop method at 4 oC over a well solution of 0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3 % trimethylamine N-oxide, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide.
|
Resolution 1.72 Å
R-free 0.202
|
|
7SJ6
T4 Lysozyme L99A/M102H with 1,2-Azaborine bound
Deposited 2021-10-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–164(164 aa)
|
Not recorded
|
B20 1,2-dihydro-1,2-azaborinine × 1
SO4 SULFATE ION × 3
BME BETA-MERCAPTOETHANOL × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277.15 K;Crystals were grown from a 5 mg/ml solution of the protein by the hanging drop method at 4 oC over a well solution of 0.1 M sodium acetate, pH 4.5, 30% (w/v) PEG-6000, 0.3 M LiSO4, 3 % trimethylamine N-oxide, 50 mM 2-mercaptoethanol, 50 mM 2-hydroxyethyl disulfide.
|
Resolution 1.72 Å
R-free 0.202
|
|
7XB5
Structure of the ligand-binding domain of S. cerevisiae Upc2 in fusion with T4 lysozyme
Deposited 2022-03-20
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–161(160 aa)
|
Mutation:R727G,C769T,C812A,I852R,I925G
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;296 K;0.1 M HEPES pH 7.0, 12.5% PEG 8000, 0.2 M sodium citrate
|
Resolution 3.44 Å
R-free 0.301
|
|
7XK9
Structure of human beta2 adrenergic receptor bound to constrained isoproterenol
Deposited 2022-04-19
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:C918T,C962A,M1096T,M1098T,N1157E,C1265A
|
GJ6 (5R,6R)-6-(propan-2-ylamino)-5,6,7,8-tetrahydronaphthalene-1,2,5-triol × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;100mM Tris-HCl, pH 8.0, 150-200mM lithium acetate, 43-45% PEG 400
|
Resolution 3.40 Å
R-free 0.261
|
|
7XKA
Structure of human beta2 adrenergic receptor bound to constrained epinephrine
Deposited 2022-04-19
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Mutation:C918T,C962A,M1096T,M1098T,N1157E,C1265A
|
G1I (5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthalene-1,2,5-triol × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;100mM Tris-HCl, pH 8.0, 150-200mM lithium acetate, 43-45% PEG400
|
Resolution 3.10 Å
R-free 0.272
|
|
7Z36
Crystal structure of the KAP1 tripartite motif in complex with the ZNF93 KRAB domain
Deposited 2022-03-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
2–161(160 aa)
Chain B
2–161(160 aa)
|
Mutation:KAP1 B-box 1 domain (residues 141-202) deleted
Mutation:KAP1 B-box 1 domain (residues 141-202) deleted
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;11% (w/v) PEG 5000 MME
5% Tacsimate
0.1 M HEPES pH 7
|
Resolution 2.80 Å
R-free 0.274
|
|
8A5X
Crystal structure of phosphatidyl inositol 4-kinase II beta in complex with MM1373
Deposited 2022-06-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–164(163 aa)
|
Not recorded
|
L6A 4-azanyl-7-[3-(hydroxymethyl)phenyl]quinazoline-6-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;10% w/v PEG 8.000, 20% v/v ethylene glycol, 3% v/v DMSO,
100 mM bicine/Trizma base pH 8.5,
20 mM 1,6-hexanediol, 20 mM 1-butanol, 20 mM 1,2-propanediol, 20 mM 2-propanol, 20 mM 1,4-butanediol, 20 mM 1,3-propanediol
|
Resolution 2.40 Å
R-free 0.231
|
|
8DCR
Cryo-EM structure of dobutamine-bound beta1-adrenergic receptor in complex with heterotrimeric Gs-protein
Deposited 2022-06-17
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
2–161(160 aa)
|
Not recorded
|
Y00 DOBUTAMINE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å
|
|
8DCS
Cryo-EM structure of cyanopindolol-bound beta1-adrenergic receptor in complex with heterotrimeric Gs-protein
Deposited 2022-06-17
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
2–161(160 aa)
|
Not recorded
|
P32 Cyanopindolol × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.50 Å
|
|
8EIT
Structure of FFAR1-Gq complex bound to DHA
Deposited 2022-09-15
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
2–161(160 aa)
|
Not recorded
|
HXA DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
8THK
Cryo-EM structure of A61603-bound alpha-1A-adrenergic receptor in complex with heterotrimeric Gq-protein
Deposited 2023-07-17
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
2–161(160 aa)
|
Not recorded
|
CGZ N-[(5S)-5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å
|
|
8UGW
Computational design of highly signaling active membrane receptors through de novo solvent-mediated allosteric networks
Deposited 2023-10-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
60–164(105 aa)
Fragment:residues 2-322
|
Not recorded
|
NGI 2-[P-(2-CARBOXYETHYL)PHENYLETHYL-AMINO]-5'-N-ETHYLCARBOXAMIDO ADENOSINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7;295 K;100mM Hepes pH 7 + 27% PEG 300 + 50mM Sodium Potassium Tartrate
|
Resolution 3.90 Å
R-free 0.330
|
|
8W1V
The beta2 adrenergic receptor bound to a bitopic ligand
Deposited 2024-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–161(160 aa)
Chain B
2–161(160 aa)
|
Mutation:N187E,C1054T,C1097A
Mutation:N187E,C1054T,C1097A
|
A1AE2 (2S)-1-[(3-{1-[4-(4-{(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)butyl]-1H-1,2,3-triazol-4-yl}propyl)amino]-3-(2-propylphenoxy)propan-2-ol × 2
AV0 Lauryl Maltose Neopentyl Glycol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;100 mM Tris buffer (pH 8.0), 100 to 175 mM lithium sulfate, 38% to 42% PEG400, and 10 mM EDTA
|
Resolution 3.00 Å
R-free 0.292
|
|
8YIC
SAR247799-bound S1PR1-Gi protein complex
Deposited 2024-02-29
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
2–161(160 aa)
|
Not recorded
|
A1LYQ SAR247799 × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.47 Å
|
|
9CBL
Cryo-EM structure of epinephrine-bound alpha-2A-adrenergic receptor in complex with heterotrimeric Gi-protein
Deposited 2024-06-19
|
Different oligomeric state
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
2–161(160 aa)
|
Not recorded
|
ALE L-EPINEPHRINE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
9CBM
Cryo-EM structure of dexmedetomidine-bound alpha-2A-adrenergic receptor in complex with heterotrimeric Gi-protein
Deposited 2024-06-19
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
2–161(160 aa)
|
Not recorded
|
CZX 4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9HC0
Dark structure of the human metabotropic glutamate receptor 5 transmembrane domain bound to photoswitchable ligand alloswitch-1
Deposited 2024-11-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–162(161 aa)
|
Mutation:E579A,N667Y,I669A,G675M,T742A,S753A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
OLA OLEIC ACID × 5
4YI 2-chloranyl-~{N}-[2-methoxy-4-[(~{E})-pyridin-2-yldiazenyl]phenyl]benzamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.2;293 K;PEG300, di-ammonium hydrogen phosphate, 1,6-hexanediol, BIS-TRIS
|
Resolution 2.33 Å
R-free 0.271
|
|
9HC3
Apo-state structure of the human metabotropic glutamate receptor 5 transmembrane domain freeze-trapped after light activation of photoswitchable ligand alloswitch-1
Deposited 2024-11-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–162(161 aa)
|
Mutation:E579A,N667Y,I669A,G675M,T742A,S753A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
OLA OLEIC ACID × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.2;293 K;PEG300, di-ammonium hydrogen phosphate, 1,6-hexanediol, BIS-TRIS
|
Resolution 2.90 Å
R-free 0.302
|
|
9HHM
Crystal structure of phosphatidyl inositol 4-kinase II beta in complex with HH5129
Deposited 2024-11-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–164(163 aa)
|
Not recorded
|
A1IVA (1~{S},2~{S},4~{S},5~{R})-6-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-bis(oxidanylidene)-$l^{6}-phosphanyl]oxy-bis(oxidanylidene)-$l^{6}-phosphanyl]methyl-bis(oxidanylidene)-$l^{6}-phosphanyl]oxycyclohexane-1,2,3,4,5-pentol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;100 mM HEPES, pH 7.0;
15 % (w/v) PEG 4,000
|
Resolution 2.25 Å
R-free 0.240
|
|
9HHM
Crystal structure of phosphatidyl inositol 4-kinase II beta in complex with HH5129
Deposited 2024-11-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2–164(163 aa)
|
Not recorded
|
A1IVA (1~{S},2~{S},4~{S},5~{R})-6-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-bis(oxidanylidene)-$l^{6}-phosphanyl]oxy-bis(oxidanylidene)-$l^{6}-phosphanyl]methyl-bis(oxidanylidene)-$l^{6}-phosphanyl]oxycyclohexane-1,2,3,4,5-pentol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;100 mM HEPES, pH 7.0;
15 % (w/v) PEG 4,000
|
Resolution 2.25 Å
R-free 0.240
|
|
9Q1F
Choanoflagellate Salpingoeca macrocollata STING
Deposited 2025-08-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–161(161 aa)
Chain B
1–161(161 aa)
|
Not recorded
|
1SY cGAMP × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.65;293 K;5% ethylene glycol, 100 mM MOPS pH 6.65, and 10% (w/v) PEG8000
|
Resolution 2.65 Å
R-free 0.275
|
|
9RKF
Dark structure of beta-2 Adrenergic receptor with photoazolol in Dark state recorded at SwissFEL
Deposited 2025-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–162(161 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 5
CLR CHOLESTEROL × 3
12P DODECAETHYLENE GLYCOL × 3
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 5
1PE PENTAETHYLENE GLYCOL × 1
EDO 1,2-ETHANEDIOL × 1
GOL GLYCEROL × 1
A1JHU ~{N}-[4-[(~{E})-[2-[(2~{S})-2-oxidanyl-3-(propan-2-ylamino)propoxy]phenyl]diazenyl]phenyl]ethanamide × 1
PLM PALMITIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;289 K;100mM tri-sodium citrate pH= 6.2, 245mM Li2SO4, 32% PEG 350 MME, 10uM photoazolol-1
|
Resolution 2.45 Å
R-free 0.219
|
|
9RKG
Mixed model refinement of beta-2 Adrenergic receptor with photoazolol in dark state and Light state, 10 seconds after light activation, recorded at SwissFEL
Deposited 2025-06-13
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
SO4 SULFATE ION × 6
ACM ACETAMIDE × 1
CLR CHOLESTEROL × 3
PLM PALMITIC ACID × 1
12P DODECAETHYLENE GLYCOL × 3
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 5
1PE PENTAETHYLENE GLYCOL × 3
EDO 1,2-ETHANEDIOL × 2
GOL GLYCEROL × 1
A1JHU ~{N}-[4-[(~{E})-[2-[(2~{S})-2-oxidanyl-3-(propan-2-ylamino)propoxy]phenyl]diazenyl]phenyl]ethanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;289 K;100 mM tri-sodium citrate (pH= 6.2), 245 mM Li2SO4, 32% PEG 350 MME, 10 uM photoazolol-1
|
Resolution 2.45 Å
R-free 0.217
|
|
9RKH
Dark structure of beta-2 Adrenergic receptor with photoazolol in Dark state recorded at LCLS
Deposited 2025-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–162(161 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 5
CLR CHOLESTEROL × 2
PLM PALMITIC ACID × 1
12P DODECAETHYLENE GLYCOL × 3
A1JHU ~{N}-[4-[(~{E})-[2-[(2~{S})-2-oxidanyl-3-(propan-2-ylamino)propoxy]phenyl]diazenyl]phenyl]ethanamide × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 7
EDO 1,2-ETHANEDIOL × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;289 K;100 mM tri-sodium citrate (pH= 6.2), 245 mM Li2SO4, 32% PEG 350 MME, 10 uM photoazolol-1
|
Resolution 2.50 Å
R-free 0.218
|
|
9RKI
Mixed model refinement of beta-2 Adrenergic receptor with photoazolol in dark state and Light state, 17 nanoseconds after light activation, recorded at LCLS
Deposited 2025-06-13
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–161(160 aa)
|
Not recorded
|
SO4 SULFATE ION × 7
ACM ACETAMIDE × 1
CLR CHOLESTEROL × 3
PLM PALMITIC ACID × 1
12P DODECAETHYLENE GLYCOL × 3
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 7
EDO 1,2-ETHANEDIOL × 2
GOL GLYCEROL × 1
1PE PENTAETHYLENE GLYCOL × 1
A1JHU ~{N}-[4-[(~{E})-[2-[(2~{S})-2-oxidanyl-3-(propan-2-ylamino)propoxy]phenyl]diazenyl]phenyl]ethanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;289 K;100 mM tri-sodium citrate (pH= 6.2), 245 mM Li2SO4, 32% PEG 350 MME, 10 uM photoazolol-1
|
Resolution 2.60 Å
R-free 0.234
|
|
9W3F
Cryo-EM structure of the human beta2-adrenergic receptor in complex with a novel antagonist
Deposited 2025-07-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–162(161 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 3.04 Å
|